Yes I know Im on holiday so Ill make it quick. Just had a phone call and an e- mail from a City pal of mine and hes drooling over this company. Hes a trust worthy chap and has given me some fantastic tips over the last 10 years.
Hes going on about it being a ten bagger, but I dont like that kind of talk, best to just see how the market rates it. He says theres going to be a lot of news flow so that should provide for a momentum driven price. Have to say I have never known him quite so excited about a stock. Ive just gone in and bought a nice holding.

Heres the e-mail he sent me. It might be worth your while having a dabble. Citywire seem to think its going to be a hit.

Health minnow makes strong return to market
Published: 11:51 Wed 22 Oct 2003
By Joanne Wallen, Associate Editor
Email to a friend


The chief of Healthcare Enterprise Group sold his last business to private healthcare firm Bupa and he's now raring to go again; the business may be worth a second look.

Shares in the 24 million AIM-listed business were suspended in August pending a couple of key acquisitions, and returned to the market on Monday after the deals were announced.


Healthcare Enterprise Group (HCEG) (HCEG) paid a total of 11.5 million for the Safa Group and Industrial Pharmaceutical Service (IPS) as well as a 60.7% stake in SafaTec. The company raised a total of 10 million via a placing of shares at 1p to fund the acquisitions and also took on 3.5 million of bank debt.


Chairman Stuart Bruck, who previously founded private medical services business Barbican, which he sold to Bupa in January 1999, is hoping to build a significant business providing medical services to corporate customers. He is hoping to be a consolidator in what he told Citywire is a very fragmented market.


Both Safa and IPS provide first aid kits, training, first aid suites and a host of other medical and occupational health services to large corporate customers such as British Airways, Marks & Spencer, BT, Sainsbury and government procurement agency OGC. Both companies also have advanced 'replenishment systems,' which enable companies to maintain adequate supplies to satisfy UK health and safety legislation.


Bruck said these acquisitions would provide a 'platform' for further acquisitions.


The company had previously accrued minority stakes in a total of 14 small healthcare services companies in the UK and the US. In March it listed on AIM by reversing into a cash shell.


Bruck said the minority stakes offered it an entry into the market, but the company has now decided to focus on wholly operating and owning businesses. It has therefore identified four of its US businesses that it would like to buy the remaining stakes in. These are all within a two hour drive of the company's Los Angeles office, and would be run from there.


The company has also 'packaged up' the remaining eight businesses with a view to selling each of its minority stakes. Bruck said the pricing being talked about is already ahead of the indicative pricing given in March.


Safa and IPS apparently already have a 30% share of the corporate medical services market in the UK. They are both cash generative from operating activities. Both companies are based in the North of England and do not have a huge penetration in London, where Bruck believes the company has 'a huge opportunity.'


He reckons they have so far penetrated around 50% of the FTSE 100, and therefore have a 'great client base' to which they should be able to sell additional services.

SafaTec has interests in a number of early stage companies that have developed some innovative healthcare products and technologies, which the company is hoping to commercialise. For example, Safa has secured a sole international distribution agreement with Ebiox, a manufacturer of a unique decontaminant and cleansing product range based on a patented formula. SafaTec UK has a 35% interest in Ebiox and HCEG is negotiating to acquire a controlling interest for the enlarged Group.


Bruck does not expect to make any more major acquisitions in the next year or so, but thinks there are a lot of small players that the company might be able to mop up.


'This is very exciting, I am looking forward to digging in,' he said.


Shares are currently at 1.7p.


Citywire Verdict:


The corporate healthcare market is becoming increasingly regulated, which favours HCEG. Bruck's track record should also be worth buying into.


The corporate structure looks pretty complicated at present with all of the minority shareholdings, but Bruck now seems keen to get the point quickly where HCEG controls the majority of the businesses it operates.


This is obviously early days, but for anyone that fancies a speculative punt on a penny share, HCEG is worth a second look.ENDS.

Well it looks very good to me although its a speculative punt, what isnt in the markets today. Good chance to get on board aswell on a bad day.

Please DYOR. You are responsible for your own buying and selling actions.

GF.

Chart showing it s move northwards on entry to the market.




gf.

1.81p = + 0.11/6.47 per cent @volume 12,092,948
Positive views from the few places I saw.However,it has only gone up 0.11 on
12M Volume despite all the dealers knowing the good news.Perhaps too many are
over cautious for some reason.Definitely worth finding more facts though.

Think it could fly in the morning.

GF

read a newspaper article a while back about how effective ebiox's decomtaminant was in a hospital test.

OK - I'm in for a few. This really does look like a 10 bagger !

Asked around relatives working in this area in North of England this morning.VERY VERY positive about the way this company operates.Never looked at this company before but have come straight in this morning to pick up a couple of grands worth. From what I hear we should expect some good news results wise within a year or so that could bring it on to a few more peoples radars.
Cheers gf.
Interesting.

It's got a very narrow spread for an AIM company - only .57% at the moment.
Overall looks good enough for me to take a small punt on.

dclinton
on the gxn thread, you said that HCEG are issuing a billion 1p shares to fund acquisitions - excuse my ignorance but what are the implications? Is that a good or bad thing for the share price, short term, long term etc?

Alot of volume today, I thought it might have gained a little.

jonfish53, me too. mainly buys, but no real moment!?

Dont forget this ones assured of plenty of news flow and at the same time price momentum newsflow. Heres a site that as tipped it..............

Taken from another thread. M Walters site I am told.
[Read more]
Battling The Bugs
21/10/2003

These days, when you go into hospital you could end up with something extremely nasty as a result of the MRSA bug. Now you can invest in a healthcare company which might have some of the answersENDS. Not a member.

But news on here should push it aswell. Cant really expect it to be up today, lets face it what is. The MMs are keeping a lid on everything. See you guys in a weeks time, having a much needed break after 5 years hard slog without one.

Might make the odd post.

GF.

Thought you were pot-holing, not making fences!

Could move up significantly on news next week.

gf.

Bought a few this morning -worth a speculative punt methinks. Is it usual for a small company like this to have such a small spread?

Bourght some this morning,could be an early xmas pressy

Such a tight spread on a 1-2p share is highly unusual - something's afoot methinks.

Dissapointing to see these drop, I think many of us are in these.
Although wasnt very impressed when i saw their website, and given they are scouse based did start to worry a bit!!!!

If anyone takes the time to read the aquisitions rns dated 20/10/03 then you'll see that this lot are a good bet long term.

even if short term they do nick your hubcaps
dyor

What ????
Liverpool the city of culture ,When they pinch the the wheels off your car these days it's left jacked up on books!

Been trying to find their website can you oblige please Pommy.
regards.

More drops today, have we been done?

Here it is

http://www.safa.co.uk/

Safa Ltd was established in 1966 and has since become a leading supplier to UK Occupational Health, where we supply many of the top FTSE listed companies. We also offer a wide range of products to First Aid Distributors and Retail Organisations.



Safa Ltd offers a range of products and services which are second to none, from information bulletins and literature to study days and seminars.



Our flexibility means that we can provide a tailor made package to meet the requirements of your business.



A range of our products are available to order on line. If you do not see what you are looking for then please contact us here at Safa Ltd.


-----------------------------------------------------------------------------

Safa Ltd is a member of The Safa Group, which incorporates Safa Ltd and Safa Medical. For further information about these companies and their services please use the navigation bar on the left.

Safa Ltd, 59 Hill Street, Liverpool, L8 5SB

Tel: 0151 708 0397 Fax: 0151 708 7211 E-mail: info@safa.co.uk

Well - hopefully he's just gathering up the small fry. Wonder if Safa would like some help with web design?

Linzimason, agreed. Didn't look that good at all really...

Mind you, I was tempted with the Dr Tooth kit. No seriously, I think the clue is in "Bruck does not expect to make any more major acquisitions in the next year or so, but thinks there are a lot of small players that the company might be able to mop up". Consolidation of lots of fragments. Maybe the website will go before long and we will see it replaced. Does HCEG have a dedicated site anyone know? Found this, dunno if it helps, but it all looks a bit fragmented. Still HCEG comes highly recommended and that's good enough for me. I like entrepreneurs.

http://www.business.com/directory/computers_and_software/computer_services/information_retrieval/healthcare_enterprise_group_plc/profile/

All Buys so far this morning and now moving north. Lets hope for somemore from this one where there is going to be plenty of newsflow which should push the price upwards.

GF.

Starting to move up now. Hoping were going to get some coverage in Shares and Investors Chronicle later this week.

cheers GF.

Having looked at this decided its worth a punt and bought a few although for some reason only one buy showing this morning and it isnt mine. You need to be on the register by the 12/11/03 to get the warrants. One warrant for every 10 ordinary shares. Gives the option to subscribe for shares @ 1.5p on the 30 June 2004 until 2008.

Ive added again this morning and nothings showing up, whats happening??????

GF.

The 100000 sell showing @ 1.62 is in fact a buy and its mine

Janus/GF - out of interest (no experience with warrants), is the register date the same as an ex-divi date; i.e., that's the day you need to hold them, so can sell before 30th June 2004 and still get option?

BTW GF - do me a favour and stick an "h" in the heading, you know what I am like for English. How was your weekend with Peggy then?

Out of this world our Linzi. Sorry about the spelling.

cheers gf.

Linzi,Once you get the warrant it becomes a share in its own right,it can be bought and sold in the market just like any other share.From tommorow you will own x amount of warrants.Your broker should inform you of this. Then you can buy, sell or hold the warrants. If you hold, once a year around June you will be offered the chance to buy shares at 1.5p.If the shares are more than than this price you will be on a good thing ,if they are lower than 1.5p you wait until next year.After x amount of years this offer expires.After tommorow you can sell the ordinary shares you hold,you will still have the warrants. But of course check this with your broker.(edit I have been informed by my broker that the ex. date is 14th Nov 03

Merci beaucoup!!

jobyjug and our linzi, its not such a bad deal that as long as you beleive in them going forward, I do.

GF.

I was'nt aware u still have the shares 2 sell after the warrant issue is this right :>}

That is correct(if we are talking about the bonus issue on ordinary shares)The expected ex. date is the 14th Nov 2003.

Tipped on the Micheal Walters, site,


Healthy Start
20/11/2003

Healthcare Enterprise Group has attracted considerable interest on its market debut. How long before the action starts?
[Read more

cheers GF.

i have sold pipex comm.(416,376) and bought in Healthcare Enterprise Group(2,075,885)shares. i think the shares are waiting to break out.

Lots of buying:

13:48 1.50p 5,000,000 Buy B
13:39 1.48p 100,000 Sell O
13:31 1.50p 66,666 Buy O
12:19 1.47p 2,500,000 Sell O
13:13 1.48p 52,982 Sell O
12:08 1.50p 2,075,885 Buy O
12:50 1.48p 128,378 Sell O
11:48 1.50p 75,000 Buy O
10:47 1.50p 350,000 Buy O
11:25 1.48p 5,524 Sell O
11:07 1.50p 70,000 Buy O
10:34 1.50p 7,851 Buy O
10:23 1.50p 10,000 Buy O
10:22 1.50p 100,000 Buy O
09:54 1.50p 30,000 Buy O
08:52 1.50p 1,000,000 Buy O
09:25 1.50p 32,371 Buy O
08:52 1.50p 2,000,000 Buy T
08:14 1.50p 131,877 Buy O
08:08 1.50p 100,000 Buy O
08:08 1.50p 30,000 Buy O
08:06 1.50p 48,951 Buy O
08:01 1.50p 100,000 Buy

Not only that RAS, but Michael Walters tipped them on friday, and is very bullish. If you want a copy of the tip send me an e-mail and I will forward it onto you. I dont mean your main e-mail say a hot mail or Lycos. Not sure you did right thing selling out of Pipex though. Both have good prospects.

cheers GF.

Goldfinger can you please forward that email from michael Walters to babar@rasool.fsworld.co.uk

Thanks

Rasool

what sort of price target are we talking about with HCEG, say in 1 years time.

I'm not too keen on buying into shares around 1p

My target for short term is 3.5p (1-3 months)
Target for longer term is 5p (6-12 months)

Trades are starting to pick up and most being buys (in Last two days):

25-Nov-2003 23,484,276 0

24-Nov-2003 24,449,552 0

21-Nov-2003 9,661,493 0

20-Nov-2003 1,292,845 0

19-Nov-2003 81,835 0

18-Nov-2003 480,112 0

17-Nov-2003 299,686 0

14-Nov-2003 5,291,127 0

13-Nov-2003 1,084,043 0

12-Nov-2003 1,142,181 0

11-Nov-2003 2,044,699 0

10-Nov-2003 1,449,710 0

07-Nov-2003 662,989 0

06-Nov-2003 57,594 0

05-Nov-2003 2,883,000 0

04-Nov-2003 654,018 0

03-Nov-2003 2,816,041 0

31-Oct-2003 1,954,337 0

30-Oct-2003 2,426,129 0

29-Oct-2003 2,617,410 0

28-Oct-2003 1,445,269 0

27-Oct-2003 4,009,513 0

Ras, e-mail on its way.

cheers GF.

Wow 6,000,000 sell just gone thru at 1.48. This investor doesn't have much confidence in the company. share price unaffected!!!

How do you know they weren't selling to invest more in RTD ?

Thanks goldfinger

rasool.

My figures taken From MoneyAM TRADES

26/11/03 Buys 8,103,953 Sells 62,716,184
25/11/03 Buys 17,902,158 Sells 8,582,119
24/11/03 Buys 15,904,371 Sells 10,125,180

Buys 41,910,482 Sells 81,423,483

So it seems mainly sells by approx 2 to 1 over the last three days.

Hope this helps.
Hopping

Interim Report For the six months ended 31 August 2003

http://www.uk-wire.com/cgi-bin/articles/200311281228076251S.html

Well done Janus, a fantastic mid term report.

Thanks for bringining it to our attention.

GF.

Now Healthcare Enterprise acquires shrewd fans

Published: 08:05 Thr 4 Dec 2003
By Algernon Craig Hall, Secret Buying Correspondent

Email to a friend

Property tycoons Nigel Wray and Nick Leslau have bought into healthcare firm Healthcare Enterprise Group.

Through Prestbury Investment Holdings, Wray and Leslau have picked up 149 million shares which takes their holding to 207 million or 7.6% of the 40.5 million group.


The company in its present form was created in March when a healthcare investment and advisory firm was reversed into a former internet company Myval bringing with it a diversified portfolio of equity investments in the sector.


Healthcare Enterprise (HTN) has been bulking up through acquisition since.


Last month the group completed the 11.9 million acquisition of three companies that supply occupational healthcare and first aid products.


The acquisitions are the company's first bite at consolidating what it views as a fragmented healthcare services market in the UK.


The enlargement of the group is also meant to establish a cash generative, base from which it can further expand, exploiting the core advisory business's international development resources.


Sounds interesting, but it is still early days. This makes Wray's and Leslau's recent purchase look an especially interesting endorsement of Healthcare Enterprise's prospects.


The market has already sat up and taken notice of the company since the reverse takeover sending the shares up from a low of 0.88p in June to today's close of 1.485p, down 0.01p on the day.


cheers GF.

GF,
there seems to be some big sells this morning. Do you think that its just one or two institutions geting out or is something about to happen that we dont know about yet.
Graeme.

Looks like institutional selling graeme. By the way NicK Leslau is a big fan of this stock and gave a very Bullish commentary on T1ps.con on the stock. Micheal walters is aswell.

Watch out for contract news very soon.

cheers GF.

High volumes and tight spreads day in and day out.

I'm confused over this as it never seems to move either way!

Seems like a potentially good speculative investment, well supported, plenty of good things said about it, well known investors in on it.

Don't know what the business end is like though, anyone care to summarise the bad and good points please?

Up 7% so far today, nice to see it moving in the right direction

Up again this morning and the warrants are up too.

Weird little share this!

You'll hurt it's feelings!

I like the rise in the warrants, I don't really have any experience with warrants or how their performance can affect the share price but if people are willing to pay over a penny at this early stage it's looking good. Of all my holdings I'm most confident with this one, for long term anyway.

Second highest gainer on the markets today. Perhaps theres news about in the city about the contact that was due before xmas.

Cheers GF.

Hope this is the start of the deals promised before Christmas.


LONDON (AFX) - Healthcare Enterprise Group PLC ("HCEG") said it has sold
its entire interests in five private healthcare/biotechnology companies to The
Empire Group Fund, LP, a Delaware chartered limited partnership.
The Empire Group Fund is managed by Empire Asset Management, LLC, an
Orlando-based advisory firm that works with small enterprises to develop their
business and marketing plans and strategies, attract investment capital, and
structure exit possibilities, including public listings in the US.
Executive chairman Stuart Bruck said the disposals represent a
rationalisation step for HCEG as it concentrates on plans to develop a
substantial healthcare services business focusing on the wholesale and consumer
markets of the UK, Continental Europe and the US.
HCEG said it has sold the companies for a 5-year loan note secured by the
interests being sold, principal amount of 2.65 mln usd, bearing interest at 5
pct per annum; 20 pct of the realised increase of each of the portfolio
interests above their base amounts; and a 20 pct limited partnership interest in
the Fund.
The loan note also provides for acceleration of all or a portion of the
repayment obligation in the event of a realisation of the underlying interests
into cash or marketable securities, depending upon the amount so realised.
HCEG said it intends to apply the proceeds from the loan note when it is
repaid for general working capital and business development purposes, and
intends to retain the limited partnership in the Fund.
The interests being disposed of are minority equity interests, equity
related securities, and the right to receive certain deferred advisory fees and
fees dependent upon fundraisings and/or certain business development activities
in the five underlying private healthcare/biotechnology companies.
newsdesk@afxnews.com
slm/

Sounds good news.....should keep rising...(famous last words!)

HCEG also mentioned in the Daily Express share whisper column today. Mentioned hopes for NHS approval for Ebiox disinfectant over the next few weeks and that Mr.Wray holds 8%.

HCEG was mentioned as a buy in City Equities online article today.

Best Wishes,

Sue.

Cheers SUE. Its well worth following.

cheers GF.

More good news.


Healthcare Enterprise Group PLC
07 January 2004



Healthcare Enterprise Group PLC

Acquisition of US Healthcare Advisory Firm and Related Interest


Healthcare Enterprise Group PLC ('HCEG') has today acquired Medical Development
Specialists, Inc. ('MDS'), a California-based healthcare advisory company, and
has also acquired from Philip Dalton, Chief Executive Officer of MDS, a 50%
interest in Strategic Creative Solutions, LLC ('SCS'), a healthcare marketing
and advertising firm (collectively, the 'Acquisitions').


MDS is a provider of planning, policy, and advisory services to health systems,
hospitals, health plans, businesses, and government. Through its relationship
with SCS, MDS also provides marketing and advertising services to these
organisations. Although MDS and SCS were formed in early 2003, they incorporate
substantial expertise from broadly recognised senior healthcare consultants.
The principal purpose of the Acquisitions is to provide HCEG with a proven
platform from which to provide strategic and commercial healthcare advisory
services.


For the ten-month period ended 31 October, 2003, MDS and SCS generated $319,419
and $327,330, respectively, in gross revenues and $51,607 and $100,914,
respectively, in profits.


The acquisition of MDS is structured as a merger of MDS with and into a
wholly-owned subsidiary of HCEG formed especially for the purposes of this
transaction. The initial consideration for the Acquisitions comprises the issue
of 20,478,374 ordinary shares to the MDS shareholders. At the current HCEG
share price as at close of business on 6 January 2004 of 1.69p this equates to
an initial value of 346,085.


HCEG has also agreed to pay further contingent consideration by issuing in
installments up to the lesser of: (i) 100 million shares; or (ii) shares with a
value of $6 million by reference to the relevant market price of HCEG's shares
(and this monetary cap also applies to any shares issued to satisfy any
liability of HCEG under a tax gross up) depending upon the accomplishment of
certain financial milestones of MDS over a three year period.


In addition, Mr. Dalton, the principal shareholder and operator of MDS, will
remain with the business as an employee and will be granted options over 40
million ordinary shares 20 million of which will vest on grant and the balance
over the three-year period.


Stuart Bruck, Executive Chairman, stated:

'MDS provides HCEG with the required position in the market to build its
international healthcare advisory platform that will focus on medical products
and services.'

'Philip Dalton, the founder of MDS who brings with him 25 years of successful
commercial healthcare advisory and management expertise to our company, will
report to Michael Low, the Chief Executive of our Advisory and Management
Services business, and spearhead the effort of growing our advisory service
business in the US, UK, and Germany.'

'We believe that the acquisition of MDS, under the direction of Philip Dalton
and our management team, should be accretive to the value of HCEG.'


HCEG is an international healthcare services company focused on occupational
healthcare, private healthcare services, and distribution of medical devices.



7 January 2004

All this good news isnt doing much for the share price.

Re. The recent disposal, which looks OK to me.

HCEG have sold certain interest to The Empire Fund LP (The Fund)
for a 5 year loan note of $2.65 @ 5% per annum.

If The Fund sells the interests during the next 5 years HCEG will receive $2.65 million
plus 5% interest up to the sale date.

If they sell the interests at a profit HCEG will receive 20% of the profit.

As a partner in the Fund HCEG will receive 20% of any profit the Fund makes on all its
Dealings.

Of course if the Fund were to fold HCEG gets nothing.

Had this piece e- mailed to me tonight.

Shrewd Tip: A healthy start to the year

Published: 14:30 Wed 7 Jan 2004
By Algernon Craig Hall, Secret Buying Correspondent

Email to a friend

Another day brings another deal for shrewd investor favourite Healthcare Enterprise.

The company is rapidly forming itself into two distinct but complimentary divisions: an occupational healthcare products and distribution business and a US based consultation and investment business.


Healthcare (HTN) aims to consolidate the fragmented occupational healthcare market and wants to use the distribution channels it is developing to sell the products produced by its consultancy clients and the companies in which it invests.


Executive chairman Stuart Bruck told Citywire: 'We're very focused on achieving high cash flow and this is going to be a real cashflow growth company.'


The strategy has already attracted three noteworthy shrewd fans.


Property tycoons Nigel Wray and Nick Leslau hold a 7.6% stake. AAA-rated manger Michael Barnard's top performing Marlborough UK Equity Growth unit trust holds 85 million shares or 3.1% of the 46 million company. Finally Mark Horrocks' Intrinsic Value investment trust, which enjoyed excellent performance in 2003, holds 65.5 million shares to which he last added 22 million to mid way through December.


Yesterday the young company announced it was shedding five non-core investments to focus on its 10 remaining stakes - including a holding in a company called Ebiox, which has developed a detergent to clean away the hospital super-bug.


Today Healthcare Enterprises has snapped up California-based healthcare advisory firm Medical Development Specialists (MDS) and 50% of its sister firm, Strategic Creative Solutions, which specialises in healthcare marketing and advertising.


Simon Like, Barnard's right hand man, told Citywire: 'From what I can make out this is good news all round… in a sector ripe for consolidation.'


Key to today's deal is the man who set MDS up in early 2003, Philip Dalton. Healthcare reckons new consultancy clients and investment opportunities will come flooding in thanks to his bulging Rolodex.


Dalton has been granted 20 million share options, exercisable below the current share price of 1.69p and he will be entitled to 20 million more if he stays on for the next three years. In total the options are is equivalent to 1.5% of the shares in issue before the acquisition.

Another important consideration for Healthcare is that MDS gives it a depth of knowledge of the US market and contacts with potential distributors which it previously did not have.


Healthcare is issuing 20.5 million new shares to make the acquisition, which at yesterday's closing price of 1.69p is equivalent to 350,000. In addition Healthcare will fork out the lesser of US$6 million (3.3 million) or 100 million shares on the condition that MDS reaches certain undisclosed profitability targets over the next three years.


Citywire Verdict:


Healthcare has begun with a bang in what is expected to be a very active year in terms of news flow.


There are hopes that this month will bring news on the regulatory progress for Ebiox's detergents. There could also be news on its disposable endoscopes investment and there may be new investments on the cards.


Healthcare's ambitious plans to consolidate the fragmented international occupational healthcare sector and developments from its investment arm are likely to mean newsflow remains strong in 2004.


At this stage in the company's development news looks more likely to power the shares' performance than hard financial data.


Healthcare is a speculative and risky situation and subject to the potential pitfall that early stage, expansive, would-be growth companies frequently disappear into.


However, its prospects are exciting and its backers are impressive.


For punters on the look out for some New Year spice Citywire recommends Healthcare as a speculative buy.

cheers GF.

Large volume today 51 million at the last count. Unable to tell what are sells and what are buys. Share price rising though and the warrants going up,so looks good news.

From ADVFN, Rumours of approval of its ebiox disinfectant in the NHS and US.

http://www.ebiox.co.uk/home.htm

tobyjug, from natwests site todays buy/sells - i bought these by mistake on a momentry lapse of concentration getting a real time price a while back - glad they are heading north!

16:56 1.76 284090 purchase 1.68 1.78
16:45 1.76 1000000 purchase 1.68 1.78
16:36 1.77 1000000 purchase 1.68 1.77
16:28 1.77 500000 purchase 1.7 1.77
16:25 1.76 83621 purchase 1.7 1.77
16:22 1.76 142497 purchase 1.7 1.77
16:22 1.72 400000 sale 1.7 1.77
16:02 1.72 65000 sale 1.7 1.77
16:02 1.76 500000 purchase 1.7 1.77
16:01 1.77 50000 purchase 1.7 1.77
15:52 1.76 250000 purchase 1.7 1.77
15:45 1.73 500000 sale 1.7 1.77
15:34 1.7 250000 sale 1.7 1.77
15:34 1.69 500000 sale 1.7 1.77
15:24 1.69 300000 sale 1.7 1.77
15:17 1.76 28372 purchase 1.7 1.77
15:00 1.76 25000 purchase 1.7 1.77
14:54 1.71 150000 sale 1.7 1.77
14:46 1.76 139532 purchase 1.7 1.77
14:45 1.76 100000 purchase 1.68 1.77
14:43 1.67 300000 sale 1.68 1.77
14:34 1.68 150000 sale 1.68 1.73
14:32 1.69 150000 purchase 1.66 1.69
14:29 1.66 370000 sale 1.66 1.69
14:23 1.69 41420 purchase 1.66 1.69
14:07 1.69 5917 purchase 1.66 1.69
14:03 1.68 500000 purchase 1.66 1.69
14:00 1.69 25000 purchase 1.66 1.69
13:43 1.69 50000 purchase 1.66 1.69
13:34 1.69 59100 purchase 1.66 1.69
12:58 1.69 1000000 purchase 1.66 1.69
12:57 1.68 1000000 purchase 1.66 1.69
12:51 1.69 46012 purchase 1.66 1.69
12:50 1.67 500000 sale 1.66 1.69
12:30 1.68 2000000 purchase 1.66 1.69
12:07 1.66 1100000 sale 1.66 1.69
12:03 1.66 132105 sale 1.66 1.69
11:59 1.66 7500000 sale 1.66 1.69
11:57 1.66 20000000 sale 1.66 1.69
11:55 1.68 100000 purchase 1.66 1.69
11:44 1.68 178571 purchase 1.66 1.69
11:36 1.68 120000 purchase 1.66 1.69
11:36 1.66 8400000 sale 1.66 1.69
11:35 1.68 349940 purchase 1.66 1.69
11:30 1.68 75000 purchase 1.66 1.69
11:26 1.66 250000 sale 1.66 1.69
11:16 1.69 850000 purchase 1.66 1.69
11:14 1.68 100000 purchase 1.66 1.69
11:11 1.66 50000 sale 1.66 1.69
11:05 1.66 100000 sale 1.66 1.69

Davepyle 1 Thanks for that.

See RNS ref purchase of Ebios Ltd

Healthcare Enterprise Group PLC (HCEG), the healthcare products and services
company, has agreed terms in principle to increase the Group's 35% holding in
Ebiox Ltd, an innovative developer of patented decontamination and disinfection
products, to 49% for a consideration of 15 million HCEG ordinary shares. Under
the deal, it is proposed that HCEG will be granted call options to acquire all
of the outstanding shares in Ebiox.


http://www.uk-wire.com/cgi-bin/articles/200401120700100848U.html

RNS Number:0848U
Healthcare Enterprise Group PLC
12 January 2004


Healthcare Enterprise Group PLC


PROPOSED INCREASE IN HOLDING TO 49% IN LEADING DEVELOPER OF PATENTED
DECONTAMINATION AND DISINFECTION PRODUCTS


Healthcare Enterprise Group PLC (HCEG), the healthcare products and services
company, has agreed terms in principle to increase the Group's 35% holding in
Ebiox Ltd, an innovative developer of patented decontamination and disinfection
products, to 49% for a consideration of 15 million HCEG ordinary shares. Under
the deal, it is proposed that HCEG will be granted call options to acquire all
of the outstanding shares in Ebiox.


HCEG aims to develop a substantial healthcare products and services business
focussing on both the wholesale and consumer markets. It is a leader in the
supply of products and services to the healthcare market and has a wide
distribution platform across the UK, Europe and the USA. In November HCEG
acquired interests in four new technologies, including Ebiox, which will be
integrated into its existing product range.


The Ebiox technology forms the basis of a range of decontamination products.
Through a unique action by oxidation, the product cleans to a molecular level,
destroying any bacterial organisms. These properties ensure that no resistant
strains can exist and have no side effects.


Keith MacGregor, Ebiox's Managing Director, will prior to the exercise of the
options granted to HCEG, hold 51% of Ebiox. It is proposed that he will join
HCEG's Products and Distribution Division management team.


Stuart Bruck, Chairman, Healthcare Enterprise Group PLC, commented:


'This acquisition is part of our strategy to increase our stakes in companies
where we currently have a minority interest and our aim to take control of both
the business and the sales process. Ebiox has developed an exciting range of
revolutionary decontamination and disinfection products which have world-wide
sales potential across both institutional healthcare and consumer markets.'


The proposed terms, which are subject to further due diligence and the execution
of definitive documentation, are as follows:


* The acquisition of a further 14% of the share capital of Ebiox, taking
the Group's interest to 49% for consideration of 15 million HCEG shares at
market price (which at the closing share price on 9 January 2004 equates to a
value of some 260,000);

* The grant of a call option to HCEG to acquire a further 2% for a price
of 100,000 (to be satisfied in cash and/or shares at a the option of HCEG)
exercisable up to March 2006;

* The grant of a further call option to HCEG to acquire the remaining
49%, exercisable up to April 2006, at a price to be determined by reference to
the financial performance of Ebiox, subject to a minimum price of 2 million and
a maximum price of 5 million, again to be satisfied in cash and/or shares at
the option of HCEG.


12 January 2004

todays buy/sells from gnatwest :

10:02 1.77 500000 sale 1.75 1.8
10:01 1.8 8000 purchase 1.75 1.8
09:59 1.8 11609 purchase 1.75 1.8
09:59 1.8 82227 purchase 1.75 1.8
09:48 1.8 2000000 purchase 1.75 1.8
09:34 1.8 20000 purchase 1.74 1.8
09:19 1.77 56497 purchase 1.74 1.77
09:19 1.76 350000 purchase 1.74 1.77
09:17 1.77 150000 purchase 1.74 1.77
09:17 1.77 27967 purchase 1.74 1.77
09:11 1.77 20000 purchase 1.74 1.77
09:11 1.77 50000 purchase 1.74 1.77
09:04 1.77 55373 purchase 1.72 1.77
09:02 1.77 100000 purchase 1.72 1.77
08:53 1.77 11299 purchase 1.72 1.77
08:44 1.77 150000 purchase 1.72 1.77
08:26 1.76 10600 purchase 1.72 1.77
08:25 1.76 112364 purchase 1.72 1.77
08:25 1.76 55859 purchase 1.72 1.77
08:25 1.76 100000 purchase 1.72 1.77
08:17 1.76 84602 purchase 1.72 1.77
08:16 1.76 100000 purchase 1.7 1.77
08:07 1.76 100000 purchase 1.7 1.77
08:00 1.76 10000 purchase 1.7 1.77

Hi davepyle1

I don't suppose you're the same David Pyle who used to go to DGS, left about 1964? (sorry to go off subject, btw)

Mitch

no mitch.....not even born

Think this is a new high today since I brought them to the boards atttention.

Going in for more in the morning.

cheers GF.

looks good this.....continuous small gains,v.good volumes, small spread and solid buys,

anyone have an opinion why the huge volumes recently haven't moved the price?

This one certainly appeals to me, I would regard it as a confident punt. What I currently like about this share is the fact that the spread (for a low penny share) is very close. Also the health sector is one which really can take off. Will sit and watch for a while yet and more than likely take a calculated gamble on this one.

Doshmaker...this one has been on a steady incline for a couple of weeks. Run by a very shrewd Chief Exec who has done a lot of sell offs and buys of other companies that compliment HCEG business and he has already sold a previous business to BUPA.
My view is there is only one way this company is going to go and that is North...it is just case of getting in at whatever you think is value....be lucky

an absolutely massive volume on friday - 59 million! any mystic meg predictions anyone?

55,750,000 of that volume was in a single cross trade 0.005p below the offer price.

It looks like insiders or institutions are switching stock around.

Sorry to appear ignorant (although I am!), but what is a 'cross trade'? Is it a trade between MMs?

More important, what is it likely to mean for holders of the share?

Thanks in advance

The LSE definition is "a transaction effected as an agency cross or a riskless principal transaction at the same price and on the same terms" ... in other words a block of shares are exchanged between parties where the buying and selling prices are the same (this requires one trade report and it is denoted as an "X" trade).

This can be caused by several circumstances e.g. a fund manager transfering stock from one of his funds to another, or an institution moving stock to a related company, or a large shareholder (what I called "an insider" earlier) passing on stock to another "insider" after having agreed a price.

Basically stock is being moved around and although the reason isn't always immediately clear an RNS message often appears a few days later explaining who has been buying and selling ... though sometimes nothing further happens.

ty intek...learn something every day.

Taken from todays Shares Magazine.

Healthcare Enterprise Group (AIM: HCEG) is a bit of a mystery. The company reversed into AIM-listed cash shell Interactivity Group last March and has kept a relatively low profile ever since.

The normally reticent management made more of a splash in November when it raised 10.5 million in a share placing and announced it had snapped up SAFA group, a medical product distribution and occupational healthcare company. However, little was clear from the interim results about HEGs business apart from its desire to trek the acquisition trail.

The share price tells a better story, having risen 30% from 1.5p, to 1.95p, and it looks set to climb higher.

Face to face, HEGS direction becomes clearer. American chairman Stuart Bruck is a mergers-and-acquisitions veteran In his business acumen a Gordon Gekko of the US healthcare market if you will. Rather than concentrating on blue-sky drug development, he is looking to bring his brand of healthcare M&A to bear on the UK market.

Were a transactional focused company, he explains. Weve bought a lot and intend to continue to grow in that direction.

Bruck was previously chief executive of Barbican Healthcare, sold to BUPA in the 1990s for 25 million following an initial investment of 6 million. The sector is target rich in terms of acquisition, he says. Companies are approaching us now and the profits will drop to the bottom line because we dont need their infrastructure.

Brucks focus is medical distribution and healthcare advisory businesses. The recent purchase of SAFA was canny, giving HEG a profitable medical device distribution business as well as impressive occupational health business.

Headed by Gordon Wood, who lead the management buy-out from parent Intercare(INT), SAFA provides occupational healthcare services to more than half of the FTSE 100s companies, including British Airways(BAY) as well as the Ministry of Defence.

HEGs head office is in London but the company also has bases in Los Angeles and in Germany at Volkswagens plant, where HEG provides occupational healthcare to employees.

SAFA is good solid stuff, says Bruck. It really is the cornerstone of everything else were doing. The division also has an incubator known as SafaTec, which invests in Israeli biotech companies. SAFA was very cash generative but not very sexy, explains Wood.

In 2000 the incubator invested in 10 Israeli companies and has first refusal on any medical product that makes it through. Currently in the pipeline is Ebiox, a decontamination product, which removes the biofilm that holds germs to surfaces and could be used to kill superbug MRSA and SARS. It cleans to a molecular level, says Wood, who also has high hopes of optiscope, a disposal endoscope.

The other half of HEG is its advisory business, encompassing recently acquired MDS, which provides financial analysis and market research. HEG secures revenue through management fees charged to clients and uses the division to fish for new acquisition targets.

Bruck is upbeat about 2004. Its not biotech, its not discovery, its about companies that make money, he says. I would be disappointed if operating profits dont double this year. Speculative buy.

Nice article, I'll be claiming my Moneyam sweatshirt at the end of the year!

Price is up a little--anyone heard any gossip?

briefly i hold some..mike walters has also recommended these..good long term hold

Ebiox test results
http://www.uk-wire.com/cgi-bin/articles/200402260700138429V.html

Ground-breaking too

Very positive write up in shares today - page 29 - titled Healthcare Enterprise set to clean up.

Should see more private investor buying in the next week or so then after the punters pick up the mag in WH Smiths over the weekend. Best to get in before close of play tomorrow me thinks

This company has looked like a potential 10 bagger ever since Stuart Bruck took over the helm - now with the potential of Ebiox (particularly if they can push into into the immensely lucrative US market), it appears that a mere 10 bagger is a trifle conservative.

check write up in sunday mail page 12 secret dealings

insur

I don't have access to the Sunday Mail at the moment but after past articles I have read in the paper I now consider anything I read in the Mail for entertainment value only.
Just my opinion
optomistic

optomistic, the article originated from rather a good source, it was from city wire! not that i am trying to convince you to buy or anything like that, just that trying to get to the original source of a rumour can some times pay dividends sorry about the pun!!!

Here's the summary of what was reported from the iii BB courtesy of someone elses post:

Healthcare Enterprise pulls shrewd investors:

Licht 9m shares.
Malborough UK Equity 85m shares.
Intrinsic Value Inv. 65.5m shares.
+ Mark Horrocks of above 3m shares.

Also heavily backed by Nigel Wray & Nick Leslau.

( page 12 Financial sector Mail)

Worth much more than a punt in my opinion.

Really annoying. I was on the phone with the stockbrokers in the process of buying in at 1.68 when I got bleeped to see a patient. I never got back to the stockbrokers.

Goldfinger - do you think its worth getting into this now at this price?

Does anybody know the exact number of shares in issue of this company. I find MAM shows 145m and other sites have 1.55bn, 2.3bn and 3.1bn.
Thanks sw

I thought 2.7bn - any more offers ?

Come on Goldfinger, let bob know...are they still worth buying??????

The answer to that is yes if you are an investor and look at medium to long term investments. Dont forget about the long list of pro investors in this stock including Nigel Wray who on average holds his investments for around 8 years.

If you are a short term trader no.

cheers GF.

seawatcher here you are. It certainly beats going back to tthe last results and then adding on the new shares issued.

It takes a while to load. Click on company map to the left of the page and then shares in issue on the right of the new page. Cheers Gf.

http://www.hemscott.com/equities/company/cd03931.htm

Healthcare Enterprise Group PLC
01 March 2004


Healthcare Enterprise Group Plc

Environment Protection Agency approval of Ebiox products

Healthcare Enterprise Group PLC (HCEG), the healthcare products and services
company, announces US Environment Protection Agency approval for a range of five
Ebiox decontamination products.

The products, Neozyme, Ultra P, Ultra L, RDA and SSC, are directed at the
surgical instrument cleaning market.

Stuart Bruck, Chairman, Healthcare Enterprise Group PLC, commented:

'This represents another achievement in opening up our marketplace for Ebiox.

' Yesterday we announced Laboratory results which confirm that Ebiox is highly
effective against bacterial contamination in hospitals. The laboratory results
together with this EPA approval will enable us to accelerate our marketing plan
for the products in the USA, the world's largest healthcare market.'

1st March 2004


Enquiries:

Healthcare Enterprise Group PLC Tel: 020 7659 6158

Stuart Bruck, Executive Chairman
Gordon Wood, CEO Products & Distribution Division

College Hill Tel: 020 7457 2020
Nicholas Nelson / Corinna Dorward

Note to editors

Healthcare Enterprise Group PLC

A healthcare products and services company operating via two synergistic
divisions:

HCEG Products and Distribution division provides a wide range of
healthcare products and services
HCEG Advisory and Healthcare Services division provides services to
healthcare businesses

HCEG is listed on the UK AIM stock market with its head office in London and
subsidiary offices in Manchester, Liverpool, Germany and the USA. HCEG is a
business engaged in medical product distribution, occupational health and
medical consultancy markets. These businesses underpin a range of innovative
medical devices, which will be introduced to the market via HCEG's own
distribution network on a world-wide basis.


Ebiox

Ebiox produces a range of patented cleansing and decontamination products, which
are designed to penetrate and remove the bacterial biofilm that harbours
pathogens such as prions, bacteria and viruses. Ebiox cleans surgical
instruments and surfaces to molecular level - achieving a 6-log reduction in
contamination levels.

Ebiox has a reputation for cleansing without drying or irritating the skin,
unlike alcohol-based products, which cause sore, dry hands, and therefore tend
to disincentivise hospital staff from adhering to hand hygiene protocols.

As well as the current range of products, which are now being marketed in the UK
and will shortly be introduced to the US market, Ebiox had a range of exciting
product innovations in development. These will assist in the control of MRSA and
SARS. The company also has products for the decontamination of dental aspiration
lines, hand disinfection products and retail disinfectant wipes. Ebiox has a
user-friendly alcohol free product range which is non harmful to all surfaces.


This information is provided by RNS
The company news service from the London Stock Exchange



http://www.uk-wire.com/cgi-bin/articles/200403010700139453V.html

Thanks GF - that is the site I use for such info but it's been locking me out for the last few days and Hemscott aren't responding.So do we agree that it's 2.7bn!? Thanks to all.
Looks good so far today.
sw

Looks excelent. Now up 39% since date of tip. Patience is rewarded.

cheers GF.

Ps just over 2.7bn

Not another shrewd investor in Healthcare Enterprise?

Published: 06:39 Mon 1 March 2004
By Patrick Sherwen, Deputy & Secret Buying Editor
Email to a friend

If any more shrewd investors buy shares in superbug-busting health company Healthcare Enterprise, there may not be room for anyone else to buy the shares.

The latest to join in the fun is legendary former fund manager Leonard Licht.


Licht is now a private investor but was a founder director of Mercury Asset Management, which now trades as Merrill Lynch Investment Management, and deputy chairman of Jupiter Asset Management. He has been mentor to several leading fund managers such as Carol Galley and William Littlewood and is respected for his smaller company stock picking ability.


Licht bought 9 million shares in Healthcare Enterprise (HCEG) at the end of last month, which gives him control over 0.33% of the 54.4 million company. With this investment he joins AA-rated Michael Barnard, whose Marlborough UK Equity Growth fund Marlborough UK Equity Growth owns 85 million shares and Mark Horrocks, whose Intrinsic Value investment trust (IV.) holds 65.5 million shares in addition to a 3 million-share personal stake. It is also heavily backed by entrepreneurial investors Nigel Wray and Nick Leslau.


The Artemis UK Alpha investment trust (ATS) run by AA-rated John Dodd has 18.5 million shares but unlike the others, has been cutting this recently. Since November Dodd has sold 21.5 million shares.


Healthcare Enterprise's most significant product from a commercial perspective is Ebiox, an unusually effective decontaminant. It takes effect in 30 seconds rather than the more usual five minutes for rivals. Last week National Health Service tests found it to be effective in killing the MRSA 'superbug' when used on hands, work surfaces and floors, which means it can now be sold to hospitals.


The stock has virtually doubled to 2.14p in the last year. It is still loss making and very high risk but the high quality backing and recent good news are very encouraging.


* This article also appeared in yesterday's Financial Mail on Sunday

cheers GF.

Looks like a winner.
rgds aj

I love it when this happens!

Only wish I'd bought more now! We're never happy are we!

Should you buy still? Difficult call, but med to long term these will be a sound investment if Ebiox takes off in the US and then world wide. I'd like to see someone far more intelligent than me predict a forecast of potential earnings, considering this is the ONLY product known to destroy the bugs it does actually do!

The spread is only 2% or so, which is ridiculously tight for a penny share that is on the up. It has been like this throughout its rise up from the 1.5p mark when I started watching it.

Short term this may drop on profit taking, but it has proved that it can sustain a rise over the past few months without too sharp a drop. Check the chart if you don't believe my mad rantings!



I must say that Goldfinger has once again come up trumps with a quality smaller company tip. Thanks big man!

I back that--thanks G F. I am holding and hoping!

Cheers guys. We may even get Mags and share tip sheets tipping this one at the week end, dont forget its that monthly time again when they all come out.

Cheers GF.

ps, this from front page.........

Healthcare Enterprise has put on 26% to 2.465p over five days. On 26 February it said its Ebiox cleansing and decontamination products have shown to be an effective solution for eradicating bacteria, including the MRSA hospital 'superbug', both in hand contact and cross contamination from bacteria-laden work surfaces and floors. Tests were carried out by the NHS Hospital Infection Research Laboratory City Hospital, Birmingham.

Just taking an interest in this stock, note todays trades in excess of 131 million, seems a lot, is this outside of the normal range?
optomistic

Yes 131 mil is higher than normal, but if you can find somewhere to check out a history of trading volumes (anyone know of anywhere that does this?), you'll see that it has consistently traded in the 10-60 million volume range.

Remember the trade value overall is low as the share price is tiny, but to have a high volume over a sustained period of time shows a certain confidence in the stock among the investors buying in. There are 2.7 billion give or take a few in issue, so the stock is extremely liquid at present, but if they continue to be hoovered up by institutions and major private investors, the calibre of those already in, then that liquidity will soon dry up.

Barring profit taking and MM manipulation (which there has been no sign of in the last 6 months at all, correct me if I'm wrong though) the price should increase steadily upwards IMHO, given the qualty of Ebiox alone. Let's hope HCEG have a good marketing and PR team in place to bring this product to the mass market in the USA and world wide.

Gary K

Yahoo provide volume data, follow this link:

http://uk.table.finance.yahoo.com/k?s=hceg.l&g=d

February's av daily trading works out at about 20 mil

Regards

PTH

Here's the monthly averages for volumes traded, quite good for a smaller company. Hopefully this will keep rising as the price does!

Date Open High Low Close Volume Adj. Close*
Feb 04 1.91 2.22 1.80 2.24 22,609,866 2.24
Jan 04 1.64 1.93 1.64 1.88 19,691,846 1.88
Dec 03 1.50 1.70 1.48 1.60 10,582,130 1.60

Thanks gary k & pth.
So today seems to have been quite an exceptional day for volumes, perhaps the reason will become clear soon.
Good luck
optomistic

The only thing that will hold this back is the massive amount of stock around.

Could see a likely consolidation on this one !

Profit taking pretty inevitable, but it has happened before and then continued to sustain its rise after a few days. Hold on as this has further to go.

Agreed that too much stock exists. Not sure if a consolidation will happen after the recent capital raising placement. Maybe more institutions buying up the stock will make it more illiquid? Let's hope so.

Consolidation today, which shows the strength of the stock as the price hasn't dropped further. Should rise again steadily in the next week or so.

Large 5,000,000 transaction @ 2.15p is listed as a sell, but more than likely a pre-ordered buy from an institution. There was a 2.5 mil transfer from MM to MM earlier in the day, which might have been the stockpiling from one trtansferred to another to satisfy the large order.

Mainly buys today, so don't panic holders, this will pick up and rise again.

Hey,
Anybody noticed the trades going through today. What a range of prices!! What's going on. Price nudging up now.
sw

Price up 3% on 200 mil sells and only 11 mil buys???????
What on earth does that mean??
PTH

This was announced yesterday. Anyone know who Nigel Wray is, and whether or not this is a good sign.

Healthcare Enterprise Group PLC
09 March 2004

HEALTHCARE ENTERPRISE GROUP PLC

TRANSFERS OF SHARES OF HEALTHCARE ENTERPRISE GROUP PLC

Healthcare Enterprise Group PLC ('HCEG') announces that it was informed
yesterday evening that Nigel Wray, who is entitled to exercise more than
one-third of the voting power at general meetings of Prestbury Investment
Holdings Limited ('Prestbury'), an existing shareholder of HCEG, has, with
effect from 4 March 2004, personally acquired 20,000,000 ordinary shares of 0.1p
each in HCEG ('Ordinary Shares') and consequently, the number of Ordinary Shares
in which he is interested either personally or by reason of his shareholding in
Prestbury has increased from 290,448,820 to 310,448,820.

In addition, Nigel Wray's infant child and certain trusts of which he is a
trustee are interested in an aggregate of 25,250,000 Ordinary Shares.

Skids, Nigel Wray "is the British Warren Buffet" according to Tom at t1ps.com.

He's a serial investor, yesterday he sold 10m shares (10.4% of company)if Stockcube and the price has dropped today. He was also involved in the debacle at Knutsford.

If he's buying a company today I would follow suit if I knew about it but keep my eyes on the price.

Anyone know of other companies he's in?

That's one clever child!!!

He usually holds for the long term and picks good companies. He bought into Domino's Pizza when they were penny shares and look at them now. I believe he is still holding.

Hes not a favourite of mine, far better to follow Mark Slater who does come up with some corkers and Angi he does a cast on t1ps abot 2 times per year. If you are a member look at the archives to find his latest casts, well worth it in my opinion.

cheers GF

Ps, did you PM me a while Back???????, lost a lot of e-mails due to NTL, my appologies if you did.

Yes Goldfinger, I did but I can't remember what about! Such a lot going on.

I've looked on the t1ps archive and Mark Slater hasn't been interviewed lately. Can I find him anywhere else?

regards angi

Ebiox are proud to present the Ebiox StreamRoom, featuring a selection of short on-line video presentations about the company and the extensive Ebiox product range.

Find out from current users just how the Ebiox range has revolutionised their surgical instrumentation cleansing process
http://www.ebiox.co.uk/home.htm

Quality web site with loads of information and proof on the validity of the product.

I'd buy it! How much is it compared to other similar (but less effective) products.

How much will hospitals, etc save on compensation claims in the long term if no-one can sue for infection because of Ebiox use!

Huge potential market and business from these products should rate HCEG as a strong buy without a doubt (from me at least).

Brought to the top for poster cath.

cheers GF.

thanks GF

when r the results due for this company?

Many more to follow hopefully.

UK smallcap opening - Healthcare Enterprise tick up on NHS deal
AFX


LONDON (AFX) - Shares in Healthcare Enterprise Group ticked firmer as the healthcare products and services company said Vernon-Carus has been awarded a more than three-year contract to supply Ebiox cleaning wipes to the NHS.

Healthcare Enterprise has a 49 pct stake in Ebiox with options to buy the outstanding shares.

Under the contract, the cleaning wipes called Azowipe Active will be made available to all NHS hospitals in a contract to run between April 2004 and October 2007.

Healthcare shares stood 0.10 better at 2.29 by 8.23 am.

fjb/rn

sw

US news to follow too after the FDA apporovals.
maybe next month ??


good old hceg

Good day great announcement,many more to come i hope.
And a big well done to S Bruck.

Stagnating a bit now, but no worries with this company IMHO. Plenty of good news should be released in the future so long as the Ebiox sales keep improving, as they should with a product of this calibre. Just gotta hope the sales team know their onions (and cleaning products).

Buy more if they dip below 2p IMHO again. Buy more if you can afford to wait med to long term to realise your investment!

a lot of talk on television news about MRSA they may rise once people click on to what they supply

Australia and canada are good markets for hceg

Can anybody give suggestions to why the big selling off in the last couple of days....is it to do with profit taking?

benners , are you certain that they are all sells? i bought hceg this week . it came up as a sell . i asked ian from money am why and he said that there is no indication what type trades are . they basically guess from the tradeprice wether a trade is a buy or a sell . my buy price was the same as the sell price. so it appeared as a sell . i have no idea how many others appeared like this .

Ok cheers bosley!...just getting a bit concerned

It's always a tricky one, the buy/sell ratio.

I don't understand the reason fully, but apparently sometimes large orders in the morning are set at the price at that time, but are not reported until later in the day. If the price has moved up in the meantime then the reported price will be closer to the selling price and so it will show as a sell instead of a buy.

It's starting to look like a nice consolidation around the 2.20 mark. Might be time to consider topping up.

Doug

In fact, there you go. I bought 22,500 shares this morning at 2.17 and it's shown up as a Sell in the trade list.

Gone quiet on HCEG.

Anyone got any news out there????

This is still a potential gem if they get their marketing and advertising strategy right for the Ebiox range of products.

This is the latest info I could find from the Times:

http://www.timesonline.co.uk/article/0,,748-1043374,00.html

Stuart Bruck will be live on chat over on advfn at 3pm today so you can put your own questions to him.

Investors Chronicle suggests hceg at 2p one of 10 penny shares worth buying.

LOOKS LIKE INVESTORS CHRONICLE HAS A LARGE FOLLOWING HAVE YOU SEEN THE BUY VOLUME IN THE LAST TWO DAYS.DOES ANYONE KNOW WHAT THE OTHER NINE SHARES ARE?
HCEG PRICE SHOULD HAVE RISEN ATLEAST A PENNY WITH ALL THIS VOLUME!

I agree this should go far. The fact Ebiox can be used as a decontaminant against MRSA superbug must mean it will surely go far. There has been a lot of shrewd buying. Nigel Wray bought 20 million shares in March and Lich (formerly Mercury Asset) bought 9 million shares as a private investor. Also shares held in Marlborough UK Equity Growth and Artemis UK Alpha Trust so we are in good company!

WELL OVER 19MILLION BUYS AND ONLY UP 0.01 THE MM'S ARE REALLY SETTING MARKET FORCES TO WORK ON THIS ONE!

Programme on Radio 4 today between 12.00 - 13.00, (You & Yours), a section will be discussing MRSA.

saw i dont understand that too.i mean i see lots of shares rise on much less volume so .01 doesnt seem right to me.

Will try and listen to Radio 4 at 12.00. MRSA is obviously very serious and widespread (including in new hospitals) and from what I understand Ebiox works much faster than anything else and has been approved so you would think share price would reflect it!

May be we should e mail the mm's to listen to the programme!They may just be ignorant!

What a complete waste of time that radio programme was, as far as HCEG were concerned. Not even a mention of how to control hand washing with Ebios.
Oh well!!

Agree about the programme! At this rate, we are going to have to start our own PR programme for HCEG!

i agree jj50. why not ask suehelen to get on the case?

JJ50 BUT THEN WE'D LOOSE OUR CREDIBILITY,AND THE SHARE WOULD PROBABLY PLUNGE.

Good point SAW, you have the edge - shall go back to being patient, let the product speak for itself!!

Share price still stagnant.mm's just don't see things our way.I've topped up I am adamant.

Price dropped is this MM tactic or have I missed something!

anyone know why price dropped today....good time to top up

Read the ADVFN posts. Bioquell success.
sw

Read the news on Bioquell - a different sort of product? Although I suppose if it eradicates MRSA from an airborne point of view the hand wash won't be so vital!! Shall research this further.

From the Independant
26 April 2004


Hot stock of the moment has to be Bioquell, a little biotech group which has developed a vicious spray to kill the hospital superbug MRSA. Its shares are up 70 per cent in a month. But shouldn't Healthcare Enterprises be generating the same sort of excitement?

Whereas Bioquell's product is a powerful spray that is pumped into a sealed-off room, Healthcare has a stake in (and option to buy the rest of) Ebiox, a new cleaning fluid that it says is also effective against the killer bacteria. The product was developed at Porton Down as a spin-off from the war on bioterrorism.

Ebiox is sold to 20 hospitals at present as a cleaner for surgical instruments and surfaces, and it is winning new contracts all the time. The company hopes to get contracts soon for the product as a handwash as well, with this new product being marketed for the first time within the next month.

Healthcare Enterprises has a boring, cash-generating business supplying first aid kits and health and safety training to corporations in the UK such as British Airways and Marks & Spencer, which it is using to fund its racier new products.

http://news.independent.co.uk/business/analysis_and_features/story.jsp?story=515203

good find Janus

good one

Is this good news? Is it normal for people to take payments in shares in place of cash?


Healthcare Enterprise Group PLC
28 April 2004





HEALTHCARE ENTERPRISE GROUP PLC



Issue of Ordinary Shares



Healthcare Enterprise Group PLC ('HCEG') announces that it has today applied for
admission to trading on the Alternative Investment Market of the London Stock
Exchange of 1,406,750 ordinary shares of 0.1p each (the 'Shares'). Of these
shares, 1,250,000 are to be issued to Mark Stanton and 156,750 are to be issued
to Stan Yeo. Mark Stanton and Stan Yeo have provided consultancy services to
HCEG and have agreed to apply the consideration payable by HCEG to them in
respect of these services to subscribe for the Shares.





28 April 2004




Enquiries:


Healthcare Enterprise Group PLC Tel: 020 7659 6158
Stuart Bruck, Executive Chairman

College Hill Tel: 020 7457 2020
Nicholas Nelson/Corinna Dorward




http://www.uk-wire.com/cgi-bin/articles/200404281019090809Y.html

Upanddown - Yes it is quite normal and it is good news as it gives them the incentive to stay with the company and produce good results for themselves (and us of course).

What is happening with this one?

Troys, nothing. Short term deviation by a few panickers following RNS,picked up yesterday,all targets met states RNS hence share issue,looking good,expect them to pick up again today.

Thanks upanddown

Whats going on? which way are these going UP OR DOWN

Up and away long term, all over the place short term.

I Agree

I will be top up at this price - WHAT A BARGAIN

this is from a poster on ADFVN and explains EBIOX it's products and various info.

came across this http://www.movisys.com/examples.htm on one of the streams it has The Ebiox StreamRoom.It explains all about ebiox etc,you require realplayer and explains what it is used for.
may be of interest.

http://observer.guardian.co.uk/uk_news/story/0,6903,1232435,00.html

Story from todays observer

hotrott

Interesting article - they certainly haven't solved the MRSA problem yet so let's hope our ebiox becomes more in demand. See you have mastered the "copy and paste" and putting it to good use already!

JJ50 could you tell me how to copy and paste

results here

Company Healthcare Enterprise Group PLC
TIDM HCEG
Headline Final Results
Released 07:00 7 Jun 2004
Number 4580Z






Healthcare Enterprise Group PLC
Preliminary Results for the year ended 29 February 2004
Maiden preliminary results since transformation into an international healthcare company focused on specialised, high-value products, supply and services in the UK, Europe and the US.


Key points


Creation of the market leader in the UK occupational health and first aid sector


Announced today: agreement to acquire First Aid UK


Acquisition of pipeline of exciting healthcare products for major market sectors


Ebiox- rollout of decontamination products to combat MRSA and other infections


Focus on UK, US and EU growth sectors in healthcare

Proposed acquisition of First Aid UK Limited



http://www.uk-wire.com/cgi-bin/articles/200406070700104564z.html

Healthcare Enterprise Group PLC
07 June 2004


Healthcare Enterprise Group PLC


Proposed acquisition of First Aid UK Limited


Consolidation of market leading position in UK occupational health and first aid
sector


Healthcare Enterprise Group PLC ('HCEG' or the 'Group'), the healthcare products
and services company, announces the signing of heads of agreement to acquire
First Aid UK Limited. The acquisition, which is subject to agreement of
definitive documentation, should further strengthen the Group's market leading
position in the niche occupational health and first aid sector. This
transaction is expected to complete shortly.

The total consideration for the acquisition will be 2 million with
approximately half payable immediately and the remainder paid as an earn-out
over two years.

First Aid UK Limited generates revenues of approximately 2 million per annum
from sales of first aid kits and products to a wide customer base including NHS
and local authority customers and high street retailers. HCEG should benefit
from the operational synergies of this acquisition in the areas of management
and product purchasing. Additionally the enlarged customer base should provide
marketing synergies through the addition of a range of important new customers
for the Group's products and services.

First Aid UK Limited will continue to operate from its premises in Cheshire with
the CEO, Andrew Pear, widening his role to join HCEG as a senior manager with
responsibilities across the Group's occupational healthcare businesses.

A further announcement will be made upon the execution of a binding share
purchase agreement.


Stuart Bruck, Executive Chairman, Healthcare Enterprise Group PLC, commented:

'When Healthcare Enterprise Group was formed, our stated aim was to take
advantage of the consolidation opportunities within the highly fragmented
marketplace for manufacturing and distributing occupational healthcare and first
aid products. This proposed acquisition would position us firmly as a leading
operator in this niche marketplace.

'Under the deal we will welcome Andy Pear to the operational management team,
who will work closely with us in the management of our combined companies in the
UK.'

Its taken some time but there is now a website

http://www.hce-group.com/

Healthcare Enterprise Group PLC
09 June 2004

Healthcare Enterprise Group PLC


German distribution agreement


Healthcare Enterprise Group PLC ('HCEG' or the 'Group') the healthcare products
and services company announces its initial step into the German healthcare
products market, with the appointment of Distrimatch GmbH as the distribution
partner to Safa-IPS Healthcare Ltd, HCEG's first aid and occupational healthcare
products division. The agreement covers the distribution of disposable and
consumable, non-durable medical products covering the markets of Germany,
Switzerland and Austria.

Distrimatch has commenced the supply of a range of products, from Safa-IPS
Healthcare to Asklepios Kliniken GmbH, one of Germany's largest private hospital
chains.

Distrimatch, which is 18% owned by Healthcare Enterprise Group, has operated
from offices on the Volkswagen Innovations Campus in Wolfsburg, Germany for over
three years. The company has a comprehensive distribution database specialising
exclusively on medical products and devices.


Stuart Bruck, Executive Chairman, Healthcare Enterprise Group PLC commented:

'Beyond our 18% holding in Distrimatch, this is the first step in a series of
planned moves by the Group to gain a foothold in Germany, the third largest
healthcare market in the world.'


William Klebusch, Managing Director, DistriMatch GmbH commented:

'The Asklepios Kliniken GmbH with its 83 hospitals, represents a noteworthy
entry point for HCEG into the German market. We are currently working to
rapidly expand our product range into this strategic customer. In addition, we
see many commercial applications for HCEG's exclusive medical technologies which
we will actively implement.'



9 June 2004

Enquiries:

Healthcare Enterprise Group 020 7351 7500
Stuart Bruck, Executive Chairman
Gordon Wood, Group Chief Operating Officer

College Hill 020 7457 2020
Nicholas Nelson
Corinna Dorward








This information is provided by RNS
The company news service from the London Stock Exchange

Healthcare Enterprise Group PLC
08 July 2004


Healthcare Enterprise Group PLC

Acquisition of Optiscope Technologies Ltd
Proprietary technology for disposable endoscopes

Healthcare Enterprise Group PLC ('HCEG'), the healthcare products and services
company, announces the acquisition of a controlling interest in Optiscope
Technologies Ltd. ('Optiscope'), a developer of disposable rigid endoscopes
using proprietary technology. HCEG believes that, as the only disposable
endoscope in the market, Optiscope has significant advantages over endoscopes
currently in use, which will underpin the adoption of the product throughout
hospitals and clinics worldwide.

Pursuant to the Acquisition, in exchange for an investment of US$100,000, HCEG,
through its controlling interest in SafaTec (UK) Limited, increased its holding
in Optiscope from approximately 32% to 55% of its outstanding shares. The
Acquisition entitles HCEG to appoint a majority of the Optiscope Board of
Directors, and gives HCEG purchase and forced sale rights over certain of the
remaining Optiscope shares held by minority shareholders.

An endoscope is a surgical optical instrument for the examination of internal
tissues and organs in the body and is an aid to surgical operations. According
to research data compiled by HCEG, the worldwide market size for rigid
endoscopes is approximately $165 million per annum and growing.

The cost of a comparable re-useable rigid endoscope incorporating fibre optics
is circa $3,000 per instrument. These are frequently damaged during use,
resulting in costly repairs. They also require disinfection, decontamination,
sterilization and servicing following each operation and, with a life span of
approximately 200 operations, the estimated cost per use is $40.

Optiscope utilizes a revolutionary, patented method of binging light to the
optical view without the use of expensive and fragile fibre optics. The viewing
tube utilizes plastic lenses thus allowing the Optiscope to be fully disposable
after use. This gives Optiscope a significant clinical advantage as it
completely removes the risk of any cross contamination. Optiscope is expected to
be manufactured at a cost not exceeding $5, thus allowing hospitals the ability
to buy multiple devices and assisting in the reduction of waiting times.

Optiscope is already in early stage discussions with a number of companies, in a
wide range of medical areas, interested in licensing Optiscope products.

Optiscope is a product of the portfolio of research products from SafaTec (UK)
Limited, which was acquired by HCEG in November 2003.

Stuart Bruck, Executive Chairman, Healthcare Enterprise Group Plc commented:

'Optiscope provides HCEG with the opportunity to capitalize on the global
distribution of a truly innovative healthcare product. The cost and ease of use
implications should encourage early adoption.

'We believe that the Optiscope products, as distributed through HCEG's
distribution infrastructure, can capture substantial market position in world
healthcare markets. '

8 July 2004


Enquiries:

Healthcare Enterprise Group PLC Tel: 020 7351 7500
Stuart Bruck, Executive Chairman
Gordon Wood, Chief Operating Officer

College Hill Tel: 020 7457 2020
Nicholas Nelson / Corinna Dorward


This information is provided by RNS
The company news service from the London Stock Exchange

Are we going to see an improvement in share price after the current news relating to goverment hospitals and MRSA. Healthcare Enterprise have the answer with Ebiox.

did not search very far Gary K.

thank you john50

In Nov2003 I got some Warrants...... Then we had CONSOLIDATION in 2004 (of 25:1).....
does anyone know if the Warrants are also affected? (by the same 25:1 maybe)

I have just received a new HCEG Cert for the shares, but nothing about these Warrants.

if you have a look at trades then they are circa 1.50p so I certainly hope not

moving nicely today

Now moving into Asia with a contract win. This could really open the flood gates into that part of the world and going East will really help them move North....enjoy the ride all you HCEG holders.

Chart looks like the price will drop before rallying to 80p or,hopefully 100p in the short term.The Asian markets are enormous.

Very good news today but: More than a million buys but the price is lower at 16.30 than it was at 8 o'clock this morning. you must be right ethel. Do the mms have that much stock that they can give it away and lower the price? Stil musnt moan at this price itis nearly 3p in old money if you see what I mean.

Healthcare Enterprise Group PLC
11 February 2005


Healthcare Enterprise Group PLC

Increased shareholding in Optiscope Technologies Ltd
Development milestones achieved

Healthcare Enterprise Group PLC ('HCEG'), the international healthcare products
and services company, announces agreement to increase its shareholding in
Optiscope Technologies ('Optiscope') to 66.25% for a consideration of $100,000
payable in cash. This follows the achievement of significant development
milestones by Optiscope.

Optiscope has a range of rigid disposable endoscopes and is one of HCEG's key
portfolio technologies. In November 2004, HCEG, Optiscope and Wahl Optoparts,
part of Jenoptik AG, entered agreement to finalise the development of Optiscope
and bring it to production via a series of pre-agreed milestones leading to the
manufacture of a prototype for clinical testing. The initial important
performance indicators have been reached resulting in a planned run of 1,000 of
these devices to be available in four to six weeks.

Optiscope combines a revolutionary, patented optical design with innovative
plastic manufacturing methods and components, to produce a commercially viable
and fully disposable surgical endoscope. This gives the device a clinical and
economic advantage, by removing the risk of cross contamination normally
associated with the re-use of expensive re-usable endoscopy equipment.

Optiscope has been technically proven to match or better the performance
criteria of existing re-usable endoscopes.

In addition to the elimination of the cross contamination problem, a key
advantage of the Optiscope products are their low cost per unit. A conventional
laproscopic endoscope retails for approximately $3,000, a significant capital
investment, with cleaning, sterilisation and repair for re-use, at additional
cost and a frequent reason for the creation of bottlenecks in clinical
procedures. By offering a low cost single use, disposable alternative,
Optiscope provides an economically viable solution for budgetary constrained
hospitals worldwide.

The Optiscope family of products will be made available to hospitals and clinics
at an extremely attractive unit cost.

Stuart Bruck, Chairman, Healthcare Enterprise Group PLC, commented:

'One of our founding principles is to introduce new products into the
international healthcare marketplace which address an immediate economic and
social need. Optiscope has huge market potential as it addresses problems
common to overstretched hospitals throughout the world - eliminating cross
contamination and helping to reduce procedure times.

'Optiscope has received modification by Wahl Optoparts and has been bench tested
to exacting standards. We look forward to the next step towards
commercialisation.

'We anticipate more significant positive news relating to Optiscope in the
future.'

11 February 2005
Enquiries:

Healthcare Enterprise Group PLC 020 7351 7500
Stuart Bruck - Executive Chairman
Gordon A Wood - COO

College Hill
Nicholas Nelson/Corinna Dorward 020 7457 2020


Notes to editors

Endoscopy

An endoscope is a surgical optical instrument for the examination of internal
tissues and organs in the body and is an aid to surgical operations. According
to research data compiled by HCEG, the world-wide market size for rigid
endoscopes is approximately four to five hundred million dollars per annum and
growing.

The cost of a re-useable rigid endoscope incorporating fibre optics is circa
$3,000 per instrument. These are frequently damaged during use, resulting in
costly repairs and treatment delays. They also require disinfection,
decontamination, sterilization and servicing following each operation and, with
a life span of approximately 200 operations, the estimated cost per use is $40.



This information is provided by RNS
The company news service from the London Stock Exchange

not the response I would of expected on the shareprice,perhaps it isn't exciting enough for those who jump in and out or for a quick profit but with more good news to follow it won't be long until they breach the previous bid high of 71p.A good cheap and simple piece of equiptment which will do wonders for the company,unlike some others who keep promising Medysis for example and nothing turns up.

Ta very much Goldfinger!!!! That's several drinks I owe you now!!!

LOOKING GOOD NOW,WITH SOME BIG BUYS,HOPE TO SEE IN THE 150p TERRITARY TODAY,LETS SEE.

Has anyone any idea what has been happening with these shares today? They rose upto 140p by mid morning then collapsed down to around 115p/120p by the afternoon.

Judging from the news on MRSA in the papers and television reports I would have thought there would have been an upwards trend in the share price.

SORRY FOR MY PROJECTION TODAY,ITS BETTER TO KEEP THE MOUTH SHUT WHEN A SHARE IS RISING.

This should answer your question.


Healthcare Enterprise Group PLC
07 March 2005

Healthcare Enterprise Group PLC

Allotment of shares

Further to the announcement of 8th and 17th November 2004 relating to the
acquisition of the entire share capital of DistriMatch GmbH, Healthcare
Enterprise Group PLC announces that application has been made for 163,042
ordinary shares to be admitted to the London Stock Exchange for trading on AIM.
The ordinary shares will commence trading on AIM on 9th March 2005, bringing the
issued share capital of Healthcare Enterprise Group PLC to 150,000,860.

7th March 2005

Enquiries:

Healthcare Enterprise Group PLC 020 7351 7500
John Bradshaw, Group Finance Director

The issue of that amount of shares is irrelevant. Think more along the lines of fear and greed and retail nervousness.

nothing climbs forever and the fever has begun to be tempered maybe things will settle down until the next bug hits them.

Healthcare Enterprise Group PLC
08 March 2005


Healthcare Enterprise Group PLC

Grant of Options


Healthcare Enterprise Group PLC, the healthcare products and services company
announces that on 1 March 2005, following an annual remuneration review, it
granted options to John Bradshaw, Group Finance Director, who joined the Board
on 3 January 2005. He has been granted options over 1,000,000 ordinary shares
at an exercise price of 79.25p per share, being the closing price preceding the
date of grant. The options vest equally on the first, second and third
anniversaries of grant and expire if unexercised upon the tenth anniversary from
the date of grant.

8 March 2005


Enquiries:

Healthcare Enterprise Group 020 7351 7500
Stuart Bruck, Executive Chairman

College Hill 020 7457 2020
Corinna Dorward




This information is provided by RNS
The company news service from the London Stock Exchange

Healthcare Enterprise Group PLC
11 March 2005

Healthcare Enterprise Group PLC

Announcement of notifiable interest of shares



Healthcare Enterprise Group PLC ('HCEG') was notified on 10 March 2005 that
Morgan Stanley Securities Limited has an interest of 4,934,000 ordinary shares
in HCEG, being approximately 3.29% of the issued share capital of the HCEG.



11 March 2005






This information is provided by RNS
The company news service from the London Stock Exchange

Ticking up nicely this morning. Next stop 150p ?

Anyone got any comment on the recent drop in HCEG?

dclinton lots of info on ADVFN.com

Not a member. Care to summarize here?

Drop in price down to tree shakes and small holders seeing the value of their stock dropping .Today there have been a lot of buying around the 94-97p range,me? I bought at 103 the other day but will hold as good news is just around the corner.HCEG is very difficult to call as there isn't anything similar to it,but a decent RNS and these will rise very quickly.If you haven't now is the time to take action and buy at the present levels.You've seen what happened last time and don't forget private shareholders only hold around 12% of the stock..If MW provides an upbeat comment in his newsletter then his followers will pile in.

I've been in HCEG for some time. The price has dropped through my 15% soft-stop-loss and I need to decide whether to cut and run with the profit I have left. The lack of news is worrying but I've been over to ADVFN and had a read there and, as you say, it looks like tree shaking.

The price seems to have stabalized at about 95 for the moment and I agree that good news should lift these again. From the chart, looks like a simple 50% retracement of the recent surge so I'll hold.

Doug

Where do any one think the price can go and is it a strong buy?

155p is the figure banted about. LOL DYOR

thanx

began picking up today bid been upto 108bid /112offer thought they would return now around 100p bid stil up on day at present have seen elsewhere and looks as MW may be updating shortly on his website,but only gossip.

Here is what Numis stated.
Buy
118p
Target Price: 155p
Market Capitalisation 177m
Shares in issue 150m

Healthcare Enterprise* Based on market rating for 06/7

Update to forecasts

We last published forecasts on this company in our note of 16th December, and since that date, the shares have been recapitalised on the basis of one share for every 25 held then.

Since December there have been a number of published developments, and the company has been very busy in seeking out new business, as well as developing its portfolio.

Its business model appears to be proving successful, with good cash flow from its occupational health and first aid business, financing the development of a number of exciting new products, generally coming out of various incubator systems.

The company appears now to be making excellent progress across the business, with its distribution operation going well, and a rapid early build-up in orders for Ebiox, plus positive developments from products in development, particularly Optiscope.

As a result of these positive developments, we feel that there is now a need to revise
upwards our earlier forecasts, and on the basis of anticipated further success with orders for Ebiox in particular, we expect significant profits for the financial year just started, plus substantial growth over the next couple of years.

If anyone can tell what has changed if nothing then we are at bargain prices.

The upsurge in Avian Flu...again...Ebiox???
Wait till elections over in U.K....NHS contracts...yes
Strong sp considering rest of market...one of my favorites...weakness yesterday due to issue of new shares?
I shall be very interested to see what the morrow brings...been waiting for some news from HCEG for a while now.
Ethel

Gossip states there is a cracking write up on www.michaelwalters.com tonight, anyone seen it, or in their own words post,please and not word for word from the site as it will offend.

If the above statement correct we'd better hold onto our hats.

This is some great news !
I emailed Dr. Gordon Woods today about the S.D.A and this was his answer :
( Check out his new American address as well )
Thanks for your e-mail.



We are indeed aware of the SDA, which is an organisation primarily for US based manufacturers.



Our Group Operations Director Paul Stuart (whom joined us from Bierdorf Smith & Nephew) has just returned from the US where he has finalised a manufacturing contract with a company called Custom Chemicals Inc. whom will begin to manufacture Ebiox for us in The United States.



As sales volumes in the US begin to increase, it no longer makes sense for us to manufacture the products in the UK and ship to the US (they have enough water of their own!)

Myself and Paul will travel to China next month with a view to establishing manufacturing facilities there for similar logistical and commercial reasons.



I can confirm that Custom Chemicals are members of the SDA.



Kind Regards



Dr.Gordon A Wood
Chief Executive Officer
Healthcare Enterprise Group PLC

That is the very best of news!!
Thanks substp

Does sound like good news!

However, I have been visiting hospital in Edinburgh daily
for some weeks (Scotland appears to have quite an MRSA problem) and
although signs on wards say "visitors should wash hands on entry
and leaving wards") the gel handwash sadly does not appear to be
Ebiox.

jj, I do hope that the health authorities in general and Dr Reid in particular are fully aware of the MRSA problem in Scotland. It would be sad to think that any adverse MRSA figures are being witheld from the public eye.
As to the non use of Ebiox my personal view is that it is down to finance, the cheaper product has the 'edge'........regretable but this is often the case until it is too late.

Isn't it because NHS insists on alcohol based handwash? And in any case, HCEG is after big stuff ie USA and the East and is far ahead here.

http://news.bbc.co.uk/1/hi/programmes/newsnight/default.stm

RNS Number:2788L
Healthcare Enterprise Group PLC
20 April 2005

Healthcare Enterprise Group

Announcement of Notifiable Interest of Shares


Healthcare Enterprise Group PLC ("HCEG") was notified on 19 April 2005 that FMR
Corp and its direct and indirect subsidiaries, and Fidelity International
Limited (FIL) and its direct and indirect subsidiaries, both being
non-beneficial holders, have an interest of 6,012,334 ordinary shares in HCEG,
being approximately 4.0% of the issued share capital of the HCEG of 150,354,079
ordinary shares.



20 April 2005


This information is provided by RNS
The company news service from the London Stock Exchange
END

This is good news. LOL

Healthcare Enterprise answer to superbugs
24 April 2005

THE MRSA hospital superbug has become a hot General Election issue. Actress Leslie Ash, who nearly died after contracting a similar virus, has taken up the cause by leading a campaign to improve cleanliness in the NHS.

Whether she will be as successful as celebrity chef Jamie Oliver was in his crusade over school meals has yet to be seen. But with hospital bugs claiming 5,000 lives each year, this is an issue that no Government can afford to ignore.

One company well placed to benefit from this greater awareness of superbugs is Healthcare Enterprise. It has a unique cleaning agent, Ebiox, which has a wide range of applications. The germicide is effective against numerous organisms, including MRSA, but unlike other methods of hand cleaning, which involve abrasive alcohol-based agents, it has no toxicity problems. The basic patent runs until 2019.

Healthcare already supplies Ebiox as a surface wipe to about 80 UK hospitals. But given the scale of the superbug crisis, chairman Stuart Bruck is at a loss to explain why orders from the NHS for its Ebiox hand rub, whose efficacy is not in doubt, have yet to materialise.

But instead of blaming sclerotic NHS bureaucracy for the delay, Bruck is busy winning sizeable orders elsewhere. Significant contracts include one for pharmaceutical clean rooms in America, while interest in Asia is high, not least because Ebiox also acts against the bird-flu virus.

Potential orders from these and other markets, including household and dental, run into hundreds of millions of pounds and such is the confidence in the future that Healthcare recently bought out the minority stake in Ebiox.

But Healthcare is more than just a one-product firm. It has other products in development, notably Optiscope, which is a cheap, disposable endoscope for use in keyhole surgery. Patented until 2023, Optiscope is in the prototype stage and will target users of the 250m global market for conventional endoscopes, which are expensive to make and difficult to clean.

Midas verdict: Valuing a company such as Healthcare is difficult and forecasts are tentative. But based on research by the company's broker, Numis, Healthcare is expected to make a small profit this year, which could rise to 8.5m in 2006 and 28m the year after.

That would put the shares, now 99p, on a price-to-earnings multiple of 30, falling to just nine for 2007. While the risks associated with investing in a company like this cannot be understated, we believe Healthcare has an exciting product range and rate the shares a speculative buy.

• Midas is Edited by Patrick Tooher

seeing as it has been tipped and also following the Newsnight feature in which HCEG was pretty prominent and also believe there is a piece on the MW boards things are looking up could be an interesting week.

Another one to keep an eye on i think.

MeDilator :

http://v3.espacenet.com/textdoc?DB=EPODOC&IDX=AU2003224416&F=0

Yet more excellent news from HCEG


RNS Number:2065M
Healthcare Enterprise Group PLC
12 May 2005

HCEG formalises commercial presence in Japan

HCEG, the international healthcare products and services company has established a branch office in Tokyo, Japan. This office will trade to the healthcare, industrial, institutional and consumer markets.

The branch will be managed by Mr Yuta Ito. Mr Ito is a highly experienced healthcare products professional who is both well known and well respected in the Japanese healthcare market. He has over 20 years sector experience, most latterly with IMI and Heart Laboratories - both of which specialise in the field of medical devices.

Mr Ito will report directly to Group CEO, Gordon Wood.

Stuart Bruck, Executive Chairman, HCEG, commented:

"The significant interest for our products in Japan has necessitated the establishment of our own presence in this, the world's second largest economy.

"We are delighted to have secured the services of yet another high calibre individual who can assist us in both the commercial and technical processes unique to the Japanese market, and the establishment of distribution partners for our products across a number of market sectors."

Excellent. This company is going places. Now all we need is for the share price to follow.

International Market Intelligence is a company involved in the distribution of medical devices and equipment into the Critical Care Sector



Their main web site is in Japanese but there is an abbreviated English site at:



http://www.mmjp.or.jp/IMI/motto.htm







Likewise you can see an abbreviated English version of the Heart Labs site at







http://cc.msnscache.com/cache.aspx?q=1763351409229〈=en-GB&FORM=CVRE



I am personally delighted to have Yuta on board. He is a well know and respected operator in the Japanese market and has already assisted us in the fast tracking of some of our products through the regulatory maze that is the Japanese healthcare market.

I will be visiting a number of key potential distributors with Yuta at the end of this month and it is necessary that we have an on-site contact of this level taking care of these accounts on our behalf in Japan



Kind Regards

What, no interest? Mind you, the rival board is one of the best bbs available.

http://moneyam.uk-wire.com/cgi-bin/articles/200505270700218401M.html

Shares tightly held by intis -only around 12% in free float, excellent management, products and results. Broker target 155p.

LONDON (AFX) - Healthcare Enterprise Group PLC reported a sharp reduction in losses today on the back of a surge in turnover to 15 mln stg from 3 mln a year earlier.

The group also announced today that it has agreed its first distribution contract in China, with a major Chinese distributor, Chung Fai International Development Company.

The agreement covers the Beijing area of China with an initial 7 mln usd contract for the distribution of its Ebiox range of instrument decontamination products.

HCEG said it is also in discussions with other partners regarding distribution agreements for other areas in China.

Turning to results for the year, Healthcare said its pretax loss fell to 322,000 stg from a loss of 2.9 mln.

Chairman Stuart Bruck said that, having successfully consolidated the cash generative occupational healthcare and first aid business the group is now seeing its first product platform, Ebiox, win major initial contracts and distribution agreements.

'We are on track to launch Optiscope in 2006 having secured a significant partnership with JENOPTIK AG and there are further product platforms in the pipeline,' he added.

In the coming months, Bruck said trading should continue in line with expectations with significant newsflow on acquisitions, distribution agreements and on one or more new product platforms. newsdesk@afxnews.com

This is going to be a fantastic growth stock IMHO. Held these for about a year now. The only way is up.

zscrooge, yes, other BBoard is much better.

LOL

saw hceg for the first time today the results show that this one is a winner or I'm a dutchman

good news for the stock,good delivery by the board,obviously due a huge rise and also think other board better.

HCEG , always on the go :
"Unfortunately I will be on a plane to Japan this afternoon so the bank holiday is out for me!

That said, I am looking forward to what will hopefully be a very fruitful series of meetings firstly in Japan over the next five days, then down to Los Angeles at the weekend."

May our thoughts be with them .

HCEG claim that Ebiox kills Avian Flu Virus,meaning that it can be used to clean surfaces which might be infected.Why has the share price been allowed to languish?
IMO this company has many excellent products and should be supported by investors,not ignored.
Ethel

ethel I agree this is a very good company with excellent products. WE NEED NEWS to move this again.

What a rare and splendid opportunity to buy in to this stock i do not think that we will see this sp again on such a quality company

Loadsa

Buys coming in faster now, if your of a mind to get on board best do it today I think
Loadsa

Moving up nicely

Loadsa

There appears to be some conflicting reports about Bioquell (A Quoted Client of Investec) and HCEG . Bioquell with similar problems as HCEG was given a hold by Investec and HCEG was given a reduce .Gratefully researched by another member of this board .

Investec Widens Bioquell 05 Pretax Loss

Wednesday, September 28, 2005 12:07:36 PM ET
Dow Jones Newswires



1556 GMT [Dow Jones] Investec Securities expects Bioquell (BQE.LN) to make a pretax loss of GBP500,000 in 05 against previous expectations of break even. The move takes into account slower-than-expected trading in 1H but would have been worse were it not for IFRS, under which the company is forced to capitalize development expenditure, thus reducing operating costs. In 06 pegs pretax profit at GBP500,000 and in 07 at GBP1M. Maintains hold recommendation. Closed unchanged at 100.25p. (DWE)


Contact us in London. +44-20-7842-9464
Markettalk.eu@dowjones.com



(END) Dow Jones Newswires

September 28, 2005 11:56 ET (15:56 GMT)

Copyright (c) 2005 Dow Jones & Company, Inc.

Taken form:

http://www.newratings.com/analyst_news/article_1038205.html
--------------------------------------------------------------------------------

HCEG and Bird'flu
My non-expert understanding is that we haven't got to the Pandemic situation yet - Bird'flu is potentially dangerous to the World because it will destroy birds - whether it "crosses-over" to other animals and particularly man is another problem....indeed it's another raft of problems. Loss of wild birds will have unexpected repercussions - loss of chickens and farm animals will affect meat production for at least a year - (=so better go veggie, right now and get used to it.).
China and the far-East has been responsible for many flu epidemics and this is just another - until the strain is understood we cannot formulate a vaccine, so stories of "Stockpiles now" are meaningless - -
If HCEG surface decontaminate was widely available (it isn't), would it stop bird'flu? - I suspect it would have no effect - how are you going to prevent the spread of something that happens in the air? When birds are gathered together they breathe the same air - theat's where the spread occurs. If you were a chicken-farmer it might be sensible to wash the outhouse down but as to covering every surface - oops that is incredibly simplistic and would have little effect IMHO.
For these reasons the HCEG sp hasn't pushed up.....the human-varient isn't yet announced and may pass over.........and Ebiox hasn't started to be used in quantity - - - even our NHS seems incapable of giving alternative washes any trial - prefering to send memos to staff and orderlys to make sure they wash their hands.....yet still the fundametial problem with MRSA continues - there is no Bio -cure because we have (over?)mis-used anti-biotic medicines for many years and it is we who have created resistant-strains.
By all means clean surfaces, wash hands and so on, but I doubt it is the real answer and secretly the Market knows it.

Have a read of the 1 March RNS from HCEG which emphasizes the importance of TrionicTM in the fight against Avian Flu.
Something is happening with the sp at last with solid buying today.
If someone is willing to pay over 100 for ONE packet of Tamiflu sold on EBay,then I see no reason why investors won't pile into HCEG now that the danger seems to be getting nearer to home!
LOL Ethel

Anybody wanting to get into HCEG, todays honest interim results have seen a knee jerk drop in value of 65% an unbelievable buy situation, given the company profile I just popped another 20.5K into the portfolio
loadsa

Whilst I have been hit today badly, I have bought more to hopefully catch the bounce.

More buys than sells and increasing all the time, therefore pricing of stock is due to market sentiment on an overall down day. Really looking forward to the adjusting bounce on this one

Loadsa

Loadsa
It needs a tonic not a bounce, not looking in very good health at the moment.

Driver
I'm hoping that the smart money is following the fundamentals on this. At this time there are 800K more buys than sells and still the market is ticking it down, something is I think distorting the action considering we are looking at a company with an excellent product range and a 30M market cap. If Im wrong its going to hurt Ouch Ouch Ouch

Loadsa

Loadsa, good luck. I haven't plucked up the courage to pile in again.

Loadsa
Looks like you have got a big seller behind the scenes, keep an eye on the after hour trades.

More buys than sells ! I suggest you look at the sales showing up after hours.

Unfortunately, driver and Janus are right. For anyone without active level,
Buys total - 8,148,770 and Sales total - 15,223,654 including sales of 3 million, 1.875 million and 1 million after hours.

I am still in this one but not by choice.

From this morning's comment on HCEG from investment house Insinger de Beaufort.

"Below 15p we may be tempted to consider buying the shares given the current state of affairs."

Well people so far so good, have managed to recoup about 25% of the total loss on original punt by investing new cash at an sp of 19.34 still holding and watching @ 24.75. how do you all think the picture will look on monday? should I jump off today or wait.

Loadsa

You have done very well loadsa, but do you think they are going to continue the climb away from the bottom? difficult one!

opto
I still believe in the fundamentals of this company of those there can be no doubt in my opinion, what has to be gauged is market reaction and there lies the rub - to be or not to be that is the question

Loadsa

loadsa, agree with you on the fundamentals but we have all been so very successfully taken for fools in this one that there will be a lot of disillusioned 'investors' waiting to move out, even the institutions may be looking to reduce.
As for myself I will continue to hold in the hope that it turns out good in the end, which could be a long haul unless we get the products passed by the American authorities. All fingers crossed and hope I am afraid!

Morning opto

It would appear that Fidelity also value the fundamentals of HCEG.
Healthcare Enterprise Group PLC
21 November 2005



Healthcare Enterprise Group PLC

Announcement of Notifiable Interest of Shares


Healthcare Enterprise Group PLC ('HCEG') was notified on 18 November 2005 that
FMR Corp and its direct and indirect subsidiaries, and Fidelity International
Limited and its direct and indirect subsidiaries, both being non-beneficial
holders, have an interest of 13,517,043 ordinary shares in HCEG, being
approximately 8.5% of the issued ordinary share capital of HCEG of 158,995,877
ordinary shares.


21 November 2005
not sure what their prior holding was can anybody enlighten?

Loadsa

see quote for HCEG on 11th Oct....they were at 9,889,055 which was 6.3%

So recent buys of HCEG from Fidelity is positive

rgds...pb

I wonder if any more institutions will be declaring in the near future, every bit of good news is going to help at the moment.

Loadsa

The sp is holding up reasonably well,but for how long?Wish they would get cracking on selling Ebiox products.Seems their sales teams are not upto scratch.I feel that something is going on that we lesser shareholders are'nt privy to...but what IS it?

ethel

I cant help wondering which is the hardest nut to crack, the American authorisation system or the NHS with its inbred institutionalised precurement procedures and all that implies. Either one is all the breakthrough that HCEG needs, when you consider the rising cleanliness issues within the Health service one could perhaps assume that someone somewhere in a position of power is choosing to ingnore the benefits of Ebiox in favour of other products

Loadsa

Foxtrot Foxtrot Tango

Still ticking up

Loadsa

Was.

Could this be the winter of our discontent

Loadsa

everyone lost interest then?

Not much left to be interested in ethel, not been one of my better ventures. Yet we are still travelling....hopefully :-/

What we need is an interesting announcement from HCEG

Loadsadosh.
What we want are no more screwups,they achieved the gross and blew it.
Have heard many reasons for not quite achieving results , but an invoicing glitch takes some beating.

So,has everyone jumped ship leaving lonely me to wonder what will happen?
The lack of news is painful.Has anyone anything cheery to say ?

Nope!

AAAAAAAaaaaaaaaggggggghhhhhhhhhh........ ... .. .

16p* today on a dire update + still more money needed, just to keep this ship stationary against the tide - Ah the Rocks, the Rocks....
/
Does anyone think the Directors have earned their fat bonuses?
/
This business should be ashamed of itself and good thing they aren't supplying hospitals in the UK in any sig qty.


(Prior to consolidation) *equal 0.64pence
Just shows you that consolidations are the last refuge of wasters.
DYOR

Today 14.25p proves that in two weeks you can lose a lottle over 10% - and if you include the spread, it's nearer 15%
..About time Directors.... made a statement - but would anyone believe them?

OK I admit it, (today) I've turned!
The sp graph shows the bottom was reached about two days ago and the sp has risen nearly 4p...I just got in at 3p over the institutional buyers, so I'm reasonably satisfied I'm not buying their cast-offs.
Is this business any better than 2 days ago?
- No it's exactly the same (no RNS's), .....but what has changed is folks willing to buy several chunks of shares for cash. That means sentiment is returning -and IMHO that counts for a lot. I'm sure the products are OK, no worse than others in the market....but they will need experienced salesforce to shift 'em. I still have doubts over Management that got us here.

Expect some return before it starts to climb, back - little by little. I may have paid a tad too much; but once an Opportunity presents itself , it need nerves of steel to hold-off, in the hope of retrenchment - and that might be short-lived. To me, this looks like the bottom is "over".

Rumour of the day
Healthcare Enterprise, the AIM-listed medical products developer that has tumbled after Novembers shock profits warning, added 2p to 18p on murmurs it is in talks with Johnson & Johnson, of the US, on the licensing of its Ebiox wipes, which are used to fight hospital-acquired infections. There was also talk that the company is mulling the sale of its Warrington site.

http://www.timesonline.co.uk/article/0,,748-2045784,00.html

This could be on the road to recovery at last, there seems to be some confident buying the last few days and the sp is slowly nudging up again.

yes ,i agree with you there keepitsimple,i think there will be some better news releases in the near future,i think we will hit 20pence within two weeks,and then a steady recovery back upto 50p within 3months.this company has still got huge potential when they have sorted out some of the teething problems,good luck all.

7p is really bad news - and little prospect of any return to what Management laughingly call shareholder value - grief these were 1.30 not that long ago (13 months?)...and no "dot-com" bubble to blame - sheer incompetance and lack of sales...I suppose any company with a grandiose name like "enterprises" should be under suspicion. I sold mine at 80p at a small loss, after a consolidation that tried to hide an earlier fall.
Monkeying with share density is a no-no for me, as it usually spells trouble, IMHO.
Grr.

AGM at 9.30 really says "stay away we don't want whinging shareholders here"....that being the case I won't buy any [HCEG] and the sp can stay where it is (6p) for all I care. When this (new) Management is kicked out, then perhaps (what's left of) the business can be run by professionals...until then I give up.

Oh and please don't let's have any Exec. Rewards when they go,- just slip away one night, switching off the lights.

I have added an ever-so small purchase to my miniscule remainder-holding.
This is not because the sp is on the move, but rather I think this is the place where it will start. There is a small risk it could fall further, but the Annual Report shows that the New Management has at least understood the problem (with Warrington distribution).
If that's the case then a small punt at these prices looks like a no-brainer. They have established products but lost customers when they couldn't deliver (...I don't understand why....) but this is said to be resolved. Looking for 10m or more next year and there is a reasonable chance Ebiox will receive approval. If it does look at maybe 20p as the market gets excited, falling back a little until product starts to deliver - if they can organise that!
Once that is resolved say 12 month's time look for sub-50p if projected sales are well above 20million.
I think it will be a long road to the earlier 1+ as this Market has been spooked....
. exec rewards could still act as a ceiling.

hangon, I agree with you and bought a few recently. This could be a good recovery stock. I just hope they have not got too much long term damage as a result of the problems they had at Warrington. Ebiox should make the share price move once they have US federal approval later in the year.

Agree, stories do change and it looks like the regular healthcare business they bought was a good move. That gives them about 14million turnover with little effort (in a good year) and Ebiox is extra....both US (and NHS-sales are still possible)....but we might hope they are marketing to the Friends of Hospital (shops) where a small bottle costs nearly 5...along with anything else in the catalogue! I've seen it, it's the size of a woman's mag - thick.
.......I just hope their marketing is up to it.....
Glad you waited for 6p?.....this has been so much higher (1) -it's frightening.Thanks.

6 Sept 2006
Saw a reversal in the sp fall (to c.4p)......but now we have the spectre of a large loan facility - which gets HCEG off the hook of banrupcy but for how long ?

Under "normal" business deals cash is needed for stock and for the few days' grace to settle accounts...but if the business is not selling, any orders they get "may" be on discount.....so there is less profit.
With lower profits and a loan to service it gets worse and worse. I thought the loan facility was to fund expansion of distribution of the wonder-Ebiox - but I'm rather suspicious that we've been sold a dud and that Ebiox will not (ever) match the marketing campaigns of the Big Boys (a topic I've banged-on about when HCEG was presumed to "take-over" the World in healthcare.)... it isn't going to happen because the like of Unilever will buy a robust brand and Ebiox will stay on the shelves in Warrington.(of course Ha-Ha, they might buy Ebiox!)
We have heard very little about Approvals by NHS, or FDA - does anyone know if these are really on-going, or expected soon/later?
I'm not yet in profit, but did sell at 80p (remember those days?)- to buy again sub 20p and sub7p

Would HCEG be bankrupt soon?...thanks to the expert management!

Seems the Dirs need some of their own anti-bug medicine...... these Bu**ers must have faith in their brew? - ... it would transform them from an evil-smelling cash-wound into a neat silk purse without strings.

It is difficult to understand just how bad a business can be before there is some action....and I don't mean rewarding themselves with options.

Still, in a sad jokey way, the Market is wise to them and keeps pricing the stock just out of reach of their options. Ho! B***dy! Ho!.


Looks like I made a few bad calls on this one recently, funny that - you instinctivly know something is wrong, yet I still ask for more.
Thank goodness the investment was petty cash levels; but it still goes against the grain.

The real worry is that the business is ready for the knackers' yard and won't fetch much....maybe there will be a rendering charge. Oh dear.

My earlier Selling at 80p is a long time ago....can anyone remember when it was over 1...........grief......... and I have other work to do.............bye

Latest RNS appears to tell the Market they are buying another company with "our" shares (+dilution).

When will Dirs realise that only once in ten times does buying a company represent good value? 90% of instances it destroys shareholder value because it allows Directors to appear to be productive when really all they do is waste their time spending (large amounts of) our money.

If they want to spend money, use their own. But get out of our company first, so someone else can make good with the assets.

The directors know this. They live to make money. And the members of the authorities who govern their actions also live to make money. And they all know each other. It doesn't take much to realise that there is a little corruption out there.

Does anyone know whats happening? SP is up every day.

Interesting isn't it - languishing for ages and then this. Have to admit to a holding in these - which is at about breakeven at the moment. Possibly to do with recent announcement but I think they're even confused over on the dark side - if you want to wade through about 20,000 posts. Wouldn't recommend it - just wait until there is a RNS from the company - I suspect that the news has been leaking - or thereagain it might just be the herd getting all carried away.

Michael Walters is a holder and he did an update piece on them recently (15/01 - I think) - so I suppose he might have sparked the revival.

If you don't know their history and don't have a position - do some research on them before leaping in. Could be a good 'un BUT they have flattered to deceive before - way way down from their highs after cocking up and losing face in the market. Potential there but they can't afford to cock up again.

Regards
mg

This RNS seems to have been the start of the revival"

RNS Number:4990P
Healthcare Enterprise Group PLC
15 January 2007

15 January 2007

Healthcare Enterprise Group PLC

$4.5 million Ebiox Distribution Agreement



Healthcare Enterprise Group PLC ("HCEG", AIM: HCEG) announces that its wholly
owned subsidiary, Ebiox Limited, has secured an agreement with Sultan
Healthcare, Inc ("Sultan") for the exclusive marketing of the Ebiox range of
disinfection products to the dental sector in UK, continental Europe, Latin
America, South America, Asia and Africa.



The agreement which is for an initial term of five years, requires Sultan to
purchase a minimum US$4.5 million (#2.33 million) of Ebiox products over that
time, including US$625,000 (#325,000) in 2007, US$875,000 (#455,000) in 2008,
and US$1 million (#520,000) in each of the following three years. Sultan has
agreed to meet these minimum purchase levels as a contractual obligation,
subject only to Ebiox's capacity to supply.



Sultan is a leading US based international manufacturer of dental and medical
products which has three distribution centres; Englewood, New Jersey, USA;
Ontario, Canada and Amsterdam, Holland, supporting sales through distribution
partners into 70 countries. Distribution partners are supported by territory
managers in each market worldwide, giving Sultan wide coverage in all dental
markets.



Sultan has also been granted a non exclusive right to sell Ebiox into the
medical supply market.



In addition, as various Ebiox products receive regulatory approval, Sultan will
market the products in North America. This will be the subject of a separate
agreement with Sultan with additional purchase requirements for the North
American market.



Lyndon Gaborit, HCEG Executive Deputy Chairman commented:



"This is a significant step forward in the profitable expansion of the Ebiox
business. Sultan's choice of Ebiox as the best product to satisfy growing demand
in the dental sector for a non alcohol based suite of products, not only in the
USA but also the rest of the world, is testimony to the product's effectiveness
in decontamination and disinfection. We are delighted with this endorsement of
the Board's strategy for developing the range."



Paul Seid, President of Sultan commented:



"We are pleased to have secured exclusivity to market Ebiox disinfection
products to our dental and medical customers in these territories. Having
analysed the product we are confident about the growth opportunity this
represents for Sultan from this exciting development of our portfolio. We
believe that the Ebiox technology of non-alcohol disinfection that will remove
biofilm and clean to the molecular level is the greatest improvement on
disinfection efficiency and efficacy in 25 years. Additionally, the products
have superb compatibility with commonly used dental and medical surfaces and
materials. The Ebiox technology will certainly add to our leadership position
in infection control worldwide."

Thanks opto, had missed that RNS. It will be a long time before some of us
hit breakeven though!

Hi jj, maybe it won't be too long. This agreement opens up a huge market.

Surprised nobody has posted up the EPA announcement - looks as if the woes of HCEG are now behind them. I've got a few of these in my pension SIPP at average 7p so looking for a return to their former glory for a 10 bagger. But I'd be more than happy for a 5 bagger as a reward for patience:)

Healthcare Enterprise Group PLC
14 February 2007

14 February 2007

Healthcare Enterprise Group PLC

EPA approval for Ebiox surface hygiene products



Healthcare Enterprise Group PLC ('HCEG' or 'the Group', AIM: HCEG) is pleased to
announce that its wholly-owned subsidiary, Ebiox Limited, has secured U.S.
Environment Protection Agency ('EPA') approval for its patented concentrate and
spray disinfectants.



TruKleen, the registered trade name of the Ebiox surface hygiene products in the
U.S., offers significant advantages over other surface cleaners in the U.S.
market. By removing biofilm and cleaning to the molecular level, TruKleen is
effective against pathogens including viruses, fungi and bacteria such as MRSA.
TruKleen is free of damaging chemicals and skin irritants such as alcohols,
phenols, chlorine and aldehydes. It is therefore well suited for repeated use on
washable surfaces over protracted periods of time.



Applications for individual U.S. state approvals are being submitted immediately
and may take up to six months. These approvals will allow HCEG to distribute
TruKleen products in a wide range of markets.



Once individual state approvals are secured, HCEG will look to sign further
field of use agreements in the healthcare market and exploit additional
opportunities within broader markets such as agriculture, food processing and
facilities management.



HCEG recently announced a $4.5 million agreement over 5 years with Sultan
Healthcare Inc. ('Sultan') for the distribution of Ebiox products in the dental
market outside North America. As part of that agreement, the Group will now
commence discussions with Sultan to extend its exclusive distribution rights to
the dental market within North America with an associated additional financial
commitment.



Lyndon Gaborit, HCEG Executive Deputy Chairman commented:



'Regulatory approval in this world market is a major achievement for the Group.
The U.S. approval process for these products has taken longer than expected
owing to the unique make up of our products. This approval is a further
validation of our technology and products.'



'TruKleen has huge potential in the U.S. as these non-alcohol surface hygiene
products have significant practical advantages whilst being more effective in
cleaning and decontaminating.



'With a commitment from Sultan already endorsing Ebiox products in other
territories, we are confident that U.S. distribution contracts can be secured.'

Whilst this (US approval) is moderately good news (taken over the life of the listing), it is a pity Mangement didn't get its timing right - they ann a deal with Sultan (US distribution), and then ann the approval - it would seem to me that "with approval" the deal they could strike would be somewhat better (ie for shareholders) since the approval adds considerable value to the product - or does it?
That is my fear, despite MM's pushing the sp up 30%, due to punter frenzy - is the value already out there? - at the earlier price when Sultan deal was ann....we shall have to wait and see.
I hold from av. 10p - but let's not forget this Co trumpeted its prospects so well it oversaw a sp over 1 - and we've had several share-manipulations as the Exec Options slipped below their worst-case imagination. House of cards then? Clearly we need to see some turnover and I fail to see the point of Mangement options when the sales are conducted by outside organisations.

The company has many other products ( apart from Ebiox) - and if well presented it is possible HCEG will return to profitability - my fear is the old management was incompetant and that the case for management (today) is still far from clear.
Just how long do investors expect to remain patient?
Some big-names invested early and sadly this performance does their image no good at all; I for one suspect they have profited whilst the Public has lost-out = not only as "investors" but also as patients, where the Ebiox might have saved lives...but this aspect is yet to be proved. Can someone say if Ebiox is yet approved for use in NHS hospitals, where alcohol-based washes are specified.
I thought HCEG shouted too soon (and said so), for by raising their heads above the radar (yet without the necessary approvals) they alert the likes of Dettol (to mention one famous brand)...their TV ads now extol an ability to fight MRSA something about keeping your powder dry I think, but the Management was a rag-bag collection of chancers who fluffed it, tossed it away so many years ago.
HCEG has a lot to prove and 20million turnover would be nice, if only their warehouse could find the unlock code.
All above IMHO.

-DYOR.....this could be very good, or not!

Placing at 6p - end of Feb 07 explains why the sp is close to that figure...they raised about 1.5m to improve IT and production at Warrington ( Oh and I thought it was all sorted).
This stock has been a serial disapointer and recently went below 3p until the placing. Let's hope it adds value.
Raising new Execs more likely to be beneficial, but that's unlikely to happen...at least in the short term.

This company is going to be huge, now is the time to buy.

Well, maybe a h-disapointment, but where is there any evidence they can satisfy the healthcare market?
Not exactly active in sales, not exactly active anywhere. . . . . and the sp goes down .
Just what good news do you have?

Another good example of the risks involved if you invest in any company which does not generate cash. Not a good time to be going cap in hand to your bank, especially if your balance sheet is weak.

Oct 2007 - Shares suspended . . . whilst they look at their navels and finances.

It's difficult to find nice names to describe wasterals or scoundrells, but the fact is (if you believe they ever had a MRSA_busting product ) - they threw away a good hand . . . .and it's difficult to understand why they might do this - surely folk would be beating a path to their door? I'm sure they are all upright honest citizens, oh yes, sir.

I can only conclude we shareholders ( just a few), were not aware of the Cost of making the Ebiox- product and the Execs were more-concerned with making the business larger, by doing DEALS (never a good formula, IMHO) . . . . I distrust businesses that have no home-success before they venture for the wild West (or anywhere else I cannot reach.). . . . .
- Now, will the Banks continue to support them? . . . .

- Do you feel lucky...?

Look like the shares are back, with a small rise to 1.5pence - - - grief and these were over 1 not that long ago - but that was before they were selling the World's first superbug antiseptic which was going to do so well, they forgot to do any marketing.

Reading the RNS (Q.V.) it seems this slug of finance will repay a loan ( so someone's getting out!) and they will appoint another director to oversee the disposal of assets to produce shareholder value . . .PAH!

( -These were businesses they bought at a premium, thinking they could make a "go" of it. . . . )
To achieve s-v they need only cull all Directors and top execs who are not selling product - then sell the lot for a nominal 1 to Dettol, who will put HCEG business-plan in the shreader, then switch it ON and go to their local pub for a well-earned drink.

This outfit is incapable of - -- - just look at the sp - no need to say more; really dire. IMHO etc. DYOR.

Oh dear, too little too late.
I note that a new Director and an old one are to convert their loans into shares at a favourable price - since the inaction of the likes of the old one (by which I mean long-standing..) - have dropped so far that there is barely any space to insert a tissue paper between the sp and the graph zero-line.

This is a professionally mis-managed business and whatever share the directors arrange for themselves, they do it without any retail investor blessing....anyone care to disagree? - quoting the price you are "in" at, please.
There have been so many twists, consolidations and loans etc. that frankly I don't recall the price I bought, althou I suspect it was about 20pence - so today's sp is about 1% - but it could be 5% or .05% - - - - - frankly I have lost all interest - because whatever % these Directors own they cannot change the direction this business is moving - it's a NO-Go-er and the fall in retail investor value probably reflect the capabilities of the Directors . . . which appears to be woefully low. The opportunity to sell MRSA-non alcohol products into UK hospitals has long gone and HCEG has managed to strengthen the position of the established players. During this time they have not improved the product, neither have they done anything that makes me believe it will sell - OR - that the company has any interest in serving well those that invested. Indeed rather than attend the General Meeting ( er...?), I would be better going to the Library and catalogue old copies of the FT, in the hope I might spot a real GEM that has been overlooked by all Western Capitalists.

This stock is...... unworthy of the space it occupies... . . . . . IMHO.

Tell Nigel Wray this is one he invested in!

Oh dear, another share manipulation - if only Execs could sell the product - - - -is this never going to happen?

EDIT 19March - 20% rise Wow! but HCEG are selling the business in exchange for shares in the Purchasing co who are raising money by selling "new" shares - or did I miss something - grief this is like a game of pass the parcel - and what's in the parcel? - let's hope there is a wealthy punter somewhere - or maybe a few very fat financial hangers-on.
This is a business they "had to have" and paid a large whack for, anyone remember?
DYOR